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AFC   7-amino-4-trifluoromethyl coumarin   
AFX   acute-lymphocytic-leukemia-1 fused gene from Chr X 
AIF   apoptosis- inducing factor    
AP-1   activator protein -1     
ATF   activating transcription factor    
ATP   adenosine tri phosphate    
BSA   bovine serum albumin    
C/EBP   CCAAT/enhancer-binding protein   
Caspase   cysteine dependent aspartate specific proteinase  
Cdk   cyclin dependent kinase    
cDNA   complementary deoxy ribonucleic acid   
cGMP   cyclic guanosine mono phosphate   
CHAPS   3-cholamidopropyl-dimethylammonio-1-propanesulfonate 
CHOP   C/EBP homology protein    
CNS   central nervous system    
CRE   cAMP responsive element    
CREB   CRE-binding protein    
DEVD   aminomethylcoumarin    
DMSO   dimethyl sulfoxide     
dNTP   deoxy nucleotide tri-phosphate   
DOC   downstream of CHOP    
DTT   dithiothreitol     
DYRK1a  dual-specificity tyrosine regulated kinase 1A  
EDTA   ethylene diamine tetraacetic acid   
EGFP   enhanced green fluorescent protein   
EMSA   electro-mobility shift assay    
ER   endoplasmic reticulum    
ERSE   endoplasmic reticulum stress element   
FAD   flavine adenine dinucleotide    
FKHR   forkhead in rhabdomyosarcoma   
FKHRL1   FKHR-like 1     
FMN   flavin mononucleotide    
FOXO   Forkhead box class O    
GADD   growth arrest DNA damage    
GTP   guanosine tri phosphate    
HEPES   N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid 
HRP   horse radish peroxidase    
IAP   inhibitor of apoptosis    
IFN-gamma  interferon gamma     
 ix
IKK   IκB kinase     
IL   interlukin     
IRS   insulin response element    
JNK    Jun N-terminal kinase    
LDH   lactate dehydrogenase    
MAPK   mitogen activated protein kinase   
Mdm   murine double minute    
MPT   mitochondrial permeability transition   
NADH   nicotinamide adenine dinucleotide   
NES   nuclear export signal    
NFkB   nuclear factor k B     
NGF   nerve growth factor    
NLS   nuclear localization signal    
NO   nitric oxide     
NOS   nitric oxide synthase    
orf   open reading frame     
PAGE   poly acrylamide gel electrophoresis   
PARP   poly ADP-ribose polymerase    
PBS   phosphate buffered saline    
PCR   polymerase chain reaction    
PDK   3’-phosphoinositide dependent kinase-1  
PI3K   Phosphoinositide 3-kinase    
PKB   protein kinase B     
PLK   polo like kinase     
PMSF   phenyl methyl sulphonyl fluoride   
RE   restriction enzyme     
RNI   reactive nitrogen intermediates   
ROS   reactive oxygen species    
RT-PCR   reverse transcription – polymerase chain reaction  
SDS   sodium dodecyl sulphate    
sGC   soluble guanylyl cyclase    
SGK   serum- and glucocorticoid-inducible kinase  
SNP    sodium nitroprusside    
SOD   super oxide dismutase    
STAT   signal transducers and activators of transcription  
Tet   tetracycline     
TF   transcription factor     
TNF   tumor necrosis factor    
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SUMMARY    
Nitric oxide (NO) is a gas that potently effects changes in cells, including gene 
expression, cell cycle arrest, apoptosis and differentiation.  NO has a role to prevent 
malignancy and help fight bacterial and viral infections, as well as cause CNS injury, 
angiogenesis, ischemia, and autoimmune diseases.  All the physiological roles of NO 
are dependent on the concentration of NO and the nature of the cell type involved, 
indicating the importance of the macro and micro environment in determining whether 
NO infusion ultimately results in cell death or survival.  The mechanism of all these 
different effects, however, is still not clear.  In this study, I aimed to understand NO-
mediated regulation of gene transcription leading to cell death or survival in 
neuroblastoma cell lines by examining the roles of two transcription factors, AFX 
(acute-lymphocytic-leukemia-1 fused gene from Chr X) and CHOP (C/EBP homology 
protein).  
Forkheads are a family of transcription factors with a classical “winged helix” 
and are known to be regulators of longetivity and stress-resistance.  Here, I found 
evidence for a novel mechanism of NO affecting the AFX protein. NO appeared to 
increase the affinity of the FOXO factors to bind their consensus cis-elements and 
induced Ser-197 phosphorylation of AFX, without affecting the localization of the 
protein. Reporter assays showed a decrease in the capacity of phosphorylated AFX to 
mediate transcriptional activation following NO treatment.  Inducible over-expression 
of AFX killed cells independently of NO, indicating that AFX may play a role in 
regulating viability of neuroblastoma cells. Construction of serine to alanine and serine 
to aspartate mutants and the study of their effect on NO-mediated FOXO DNA-
binding, AFX transactivational capacity and cell survival will help us further 




CHOP (GADD153), an important player of the Endoplasmic Reticulum (ER) 
stress response pathway, is believed to be involved in a possible alternative pathway 
for NO-mediated apoptosis.  CHOP mRNA and protein levels were found to be 
induced by NO in SH-Sy5y cells.  Tet-inducible CHOP- sense and -anti-sense cell 
lines were used to further investigate the role that CHOP might play in neuroblastoma 
cells.  Cell death assays showed CHOP sense stable cells were sensitized to NO-
induced apoptosis and the anti-sense stable cells were protected from NO-induced 
apoptosis. These tools developed could be utilized to identify downstream targets of 
CHOP by differential microarray analysis, thereby helping us further understand the 
role of the ER stress pathway acting as an apoptotic trigger through the transcriptional 
activity of CHOP. 
A screening project was undertaken to determine the panel of transcription 
factors and their targets that are activated by NO.  Evidence for NO-mediated 
transcriptional up-regulation of Bcl-2 (B-cell leukemia- 2) was found.  As part of the 
follow-up of the study, I developed Bcl-2 over-expressing SH-Sy5y cells.  This study 
appears to suggest that the transcriptional up-regulation of Bcl-2 delayed cytochrome c 
release and reduced caspase-3 activity, thereby protecting neuroblastoma cells from 












CHAPTER 1  -  INTRODUCTION 
1.1 Apoptosis 
Apoptosis or programmed cell death is an evolutionally conserved mechanism for 
multi-cellular organisms to eliminate unwanted cells during development and 
homeostasis.  It is an active and highly orderly process as evident by the characteristic 
morphological changes including nuclear condensation and fragmentation, 
cytoplasmic shrinkage, plasma membrane blebbing, and exposure of 
phosphatidylserine.  The dead cells eventually fragment into membrane-bound 
apoptotic bodies, which are phagocytosed by macrophages and surrounding cells 
without inducing an inflammatory response (Yuan et al., 2003).   
With few exceptions, the terminal apoptotic programme of mammalian cells 
depends on the activation of intracellular cysteine endopeptidases called caspases and 
modification of protein substrates within the nucleus and cytoplasm.  Two overlapping 
pathways are known to be upstream of these effecter events.  The first is the activation 
of the receptor-mediated death-signaling pathways that ultimately trigger caspase-8.  
The second originates from the mitochondria, which are central targets for intracellular 
oxidative stress. Stressed mitochondria release cytochrome c and Apaf-1 (apoptotic 
peptidase activating factor 1), which contributes to a sub-organellar molecular cluster, 
called the apoptosome, which in turn activates caspase-9 (Rich et al., 2000).  Both 
these pathways can be profoundly influenced by both pro- and anti-apoptotic members 
of the Bcl-2 family, which, in turn, are regulated by various transcription factors and 
signaling pathways. The mitochondrion is the reservoir of many other death agonists 
like AIF (an NADH oxidase, a mitochondrial flavoprotein), and endonuclease G, 
which may contribute to apoptosis by a caspase-independent nuclear degradation 




1.1.1 Apoptosis in neurons 
Barring the recent discovery of neuronal stem cells indicating the possibility of 
neurogenesis in the adult brain, most neurons live as long as we do, making them 
among the most long-lived cell types.  But, neurons are not invulnerable to stress and 
homestatic signals.  Neuronal cell death helps sculpt the nervous system by removing 
excess neurons to ensure proper and precise pre- and postsynaptic connections.  
Neurons may also die prematurely in adult brains, when subjected to acute or chronic 
neurotoxic conditions caused by accidental or genetic factors (Yuan et al., 2003).  In 
fact, apart from some cases of autophagy and necrosis, it has now been established that 
approximately half of all neurons in the neuroaxis and >99.9% of the total number of 
cells generated during the course of a human life time go on to die through the process 
of apoptosis (Datta et al., 1999). 
The balance of death and survival signals tightly controls cellular apoptotic 
machinery.  In the case of neurons, NGF (nerve growth factor) is a prototypic example 
for a survival pathway.  NGF binding to its receptor tyrosine kinase, TrkA, activates a 
host of pro-survival proteins like PI-3 kinase, Akt and MAPK (mitogen activated 
protein kinase), which in turn regulate apoptosis by inhibiting pro-apoptotic proteins 
such as Bad and Forkhead factors, and by activating pro-survival proteins such as 
CREB (CRE-binding protein) and NF-κB (nuclear factor kB), which directly or 
indirectly regulate the apoptotic machinery.  These events are reversed in the absence 
of NGF (Yuan et al., 2003).  Nitric Oxide (NO) is another such signaling molecule 
known to have pleotropic effects on the cell, including maintenance of the delicate 






1.2 Nitric oxide 
1.2.1 Endogenous NO 
The synthesis of NO is catalyzed by NO synthases (NOS), a group of 
evolutionarily conserved cytosolic or membrane-bound isozymes that convert the 
amino acid L-arginine to citrulline and NO in mammalian and non-mammalian 
animals (including protozoa and insects) as well as in plants.  All NOS isoforms are 
homodimeric enzymes that require the same co-substrates (molecular oxygen, 
NADPH) and cofactors (FMN, FAD, tetrahydrobiopterin, heme, Ca2+/ calmodulin, and 
possibly, also Zn2+ ions) (Stuehr, 1999).  To date, no nucleated cell has been described 
that does not express at least one of the three major isoforms (named after the cell type 
from which they were first isolated and cloned - neuronal NOS or NOS1 or nNOS, 
inducible NOS or NOS2 or iNOS and endothelial NOS or eNOS or NOS3).  These 
NOS isoforms differ with respect to their main mode of regulation, their key functions, 
the average concentration of NO produced and their tissue expression pattern.  nNOS 
and eNOS are regulated by Ca2+ fluxes and reversible calmodulin-binding, while 
iNOS is Ca2+ independent.  iNOS, when induced in cells activated by inflammatory 
stimuli (interleukin 1, tumour necrosis factor α, interferon-γ or bacterial products such 
as lipopolysaccharide), is capable of sustained synthesis of high amounts of NO that is 
typical in inflammation.  Induction of iNOS involves a delay of 6-8 hours before the 
onset of NO production but, once induced the enzyme is active for hours to days and 
produces up to 1000-fold larger quantities of NO than the constitutive enzymes eNOS 







1.2.2 Chemistry  
Most biological functions of NO can be attributed to Reactive Nitrogen 
Intermediates (RNI), rather than NO itself.  The term RNI refers to oxidation states 
and adducts of the product of NOS, ranging from nitric oxide (°NO) to nitrate (NO3), 
analogous to reactive oxygen intermediates (ROI) that encompass intermediate 
products when oxygen is reduced to water.  In the presence of oxygen, °NO is 
oxidized to °NO2 and the reaction between °NO and °NO2 gives N2O3.  As a free 
radical, NO can quickly react with superoxide (°O2−), which leads to the formation of 
peroxynitrite (ONOO−).  Peroxynitrite is a strong oxidant, which can irreversibly 
oxidize thiol residues to sulfenic and sulfonic acids and nitrate peptides and proteins at 
the phenyl side chain of tyrosine residues.  It can also lead to the formation of °NO2 
and °OH (Bogdan, 2001).   
°NO2 can give rise to nitrite (NO2−) and/ or nitrate (NO3−), depending on the 
oxygen concentration. Synthesis of SNO (S-nitrosyl) is facilitated by electron 
acceptors or metals that mediate the formation of thiol-reactive nitrosonium (NO+) 
ions or N2O3.  S-nitrosylation is among the more studied NO modifications, because it 
fulfills the criterion of reversibility, essential for many signaling events.  S-
nitrosylation of cysteines include those that are part of intermolecular disulphide bonds 
(-S-S-), mixed disulphide bonds (-S-S-R) or cysteine sulphenic acids (RS-OH), all of 
which affect the (di)sulphide bridges that are crucial for tertiary structure and function.   
°NO can also interact with transition metals such as Fe, Zn or Cu.  The 
formation of metal-nitrosyl complexes underlies the regulatory effect of NO on a 
range of proteins including soluble guanylyl cyclase (sGC) where NO disrupts the 




proteins such as Sp1, EGR-1, vitamin D3 receptor, retinoid X receptor and mRNA 
binding proteins such as the iron-regulatory protein 1 (Bogdan, 2001). 
The reversible reactions have regulatory functions in biological systems, 
including cytoprotection, while, on the contrary, irreversible modifications are 
presumably associated with loss of protein function and cytotoxicity (Nicotera et al., 
1999). 
1.2.3 Physiological roles  
The biological attributes of NO are numerous and complex.  NO is known to 
play a fundamental role at a very early stage of development in mammals, when the 
NOS activity in male gametocytes is required for the activation of eggs immediately 
after insemination (Bogdan, 2001).  Various studies have indicated spatio-temporal 
actions of NO during embryogenesis in the formation of the central and peripheral 
nervous system, with possible involvement in processes such as neurogenesis, 
organogenesis and early physiology (Holmqvist et al., 2004). 
Nitric oxide is implicated in a broad range of physiological and patho-
physiological functions.  They include cell division, tissue differentiation, response to 
pathogens, and disease. On a positive note, they help fight malignancy and bacterial or 
viral infections, while on the other hand, they might also be involved in causing CNS 
injury, angiogenesis, ischemia, or auto immune diseases.  All physiological roles are 
dependent on the concentration of NO and the type of cell involved – indicating the 
importance of the macro and micro-environment in determining whether NO 
ultimately results in cell death or survival.  The molecular mechanism of all these 
different effects, however, is still not clear. 
A classic example for the signaling effects of NO is the relaxation of vascular 




endothelial cells.  This effect, which was the first function of NO to be discovered, is 
due to the activation of soluble heme enzyme sGC, resulting in the formation of cyclic 
GMP (cGMP), an important messenger molecule which subsequently activates cGMP-
dependent ion channels, phosphodiesterases and kinases, ultimately mediating 
vascular homeostasis (Bogdan, 2001).  
When in low levels, NO is a key signaling molecule that almost exclusively 
mediates physiological functions and counteracts patho-physiological processes in 
blood vessels, brain, kidney, heart, and many other organs.  However, at higher 
concentrations, produced mainly by iNOS and eventually also by nNOS, in the setting 
of appropriate micro-environmental conditions, it interacts with thiol groups or 
transition metal-containing proteins and can alter protein function or initiate gene 
expression to trigger cell adaptation. There is a continuous shift towards cell damage 
or apoptosis at increasing concentrations, causing tissue damage.    
Mouse knockouts of the NOS isoforms surprisingly show only limited 
phenotypes.  Though the iNOS knock out mice show an increased susceptibility to 
bacterial and viral pathogens, the other abnormalities are restricted to elevated 
systemic and pulmonary pressure and resistance to ischemic and certain inflammatory 
injury, implicating the possibility of NO and NOS’s performing possibly some 
redundant physiological roles (Mashimo and Goyal, 1999). 
1.2.4 NO in neurons 
Although NO was first discovered as an endothelium-derived relaxing factor, it 
is now clear that the brain is a primary source for its production in the body.  It is an 
important neurotransmission regulator and can inhibit the uptake of dopamine, 
noradrenaline, and serotonin (5-HT), and is able to enhance the release of 




to note that unlike other neurotransmitters, NO is not stored in synaptic vesicles and its 
action is not mediated by any specific membrane receptors, but rather through the 
cGMP channel of signal transduction.  Recent evidence also indicates that NO is an 
important player in the programme of brain development, by influencing the switch 
from the proliferative status to the differentiated state of neural progenitor cells 
(Contestabile et al., 2003).     
With respect to the neuropathological role of NO, NOS inhibitors have been 
shown to protect striatal neurons from MPTP (1-methyl 4-phenyl 1,2,3,6-
tetrahydropyridine) neurotoxicity in the mouse models for Parkinson’s disease 
(Contestabile et al., 2003).  A decrease in nNOS expression and activity in patients 
with Huntington’s disease as well as an indication of glutamate-induced neurotoxicity 
in Amyotrophic Lateral Sclerosis (ALS) and a similar co-operation between β-amyloid 
and glutamate, in vitro, are indicative of the role of NO in various neuro-pathological 
conditions.  Regionally variable decreases in catalytic activity and/or NOS expression/ 
localization in aging mice, have also indicated a role for NO in brain aging 
(Contestabile et al., 2003).   
1.2.5 Nitric oxide and apoptosis 
NO-induced cell death is important in the context of NO killing of pathogens, 
tumor cells and non-pathogenic host cells; and such cell death has been implicated in a 
wide range of inflammatory, infectious, ischemic, and neurodegenerative conditions.  
NO can cause cell death by two general pathways - necrosis and apoptosis. The former 
often results from ATP depletion, causing failure of sodium and calcium pumps – with 
energy depletion occurring largely due to inhibition of mitochondrial respiration, 
inhibition or uncoupling of glycolysis and activation of PARP.  The causes of NO-




The threshold for an apoptosis triggering effect of NO varies considerably from 
one cell to another, but there is sufficient evidence to conclude that NO mediated 
apoptosis is dependent on the mitochondria.  Inhibition of respiration, along with 
inhibition of mitochondrial enzymes including aconitase and cytochrome c oxidase, is 
known to contribute to the pro-apoptotic effect of NO via membrane potential 
reduction, transition pore opening and release of cytochrome c.  In a cell-free system 
containing mitochondria and nuclei, NO induced mitochondrial permeability transition 
(MPT) and promoted apoptosis which was inhibited by permeability transition 
inhibitors (Brune, 2003).    
Caspase-3, -7, -2 and -9 have been determined to be central components in a 
cascade triggered by NO in certain cell systems.  Processing of these caspases has 
been observed, implicating their involvement in NO mediated cell death. Besides, 
blocking of mitochondrial permeability attenuated caspase activation, further 
confirming the sequence of NO-mediated pro-death events in the cell (Bogdan, 2001). 
NO, generated either via iNOS or the breakdown of NO donors, evoked p53 
accumulation in murine macrophages (Zhou et al., 2004).  However, accumulation of 
p53 cannot be taken as proof that DNA damage is involved because NO does not 
induce significant DNA damage at the cellular level.  However, p53-null mice or 
mutant p53 human cells showed increased resistance to NO-induced apoptosis, 
underscoring the role of p53 in transmitting a pro-death NO response (Brune, 2003).  
p53 activity has been shown to be required for the up-regulation of cell cycle 
regulators such as p21or pro-apoptotic proteins such as, Bax, PUMA and NOXA. Akt 
attenuated p53-dependent transcriptional activation and suppressed NO-elicited cell 
death. NO-mediated Ser-15 phosphorylation (increases p53 stability/ activity), down-




all been implicated in the accumulation and activation of p53 (Brune, 2003). However, 
the p53 response is not operational in all cells, and alternate pathways are known to 
exist.  One of them is the ER stress pathway, induced through the unfolded protein 
response, and involves the activation of the transcription factor CHOP.  Perhaps, 
mitochondrial and downstream cascades modulated by Bcl-2 and IAP family members 
are possible intersections of p53-dependent and p53-independent apoptosis (Li et al., 
2004a). 
Bcl-2 and Bcl-XL (B-cell leukemia extra long) over-expression studies have 
shown the role played by Bcl-2 family members downstream of p53, and upstream of 
cytochrome c relocation and caspase activation.  NO-evoked decreased expression of 
anti-apoptotic Bcl-2 family members was also shown in monocytes (Brune et al., 
1999; Yabuki et al., 1997).   
Lipid peroxidation (a chain reaction that results in the oxidation of 
phospholipids to lipid hydroperoxides and in the formation of secondary diffusible 
products, such as aldehydes) is another trigger for MPT (mitochondrial permeability 
transition) and apoptosis. NO can both promote and inhibit the process – in the 
presence of superoxide, peroxynitrite generation could rapidly cause lipid 
peroxidation; while, on the other hand, NO scavenging of the hydroxyl radical (OH°) 
is also a potent inhibitor of the lipid chain reaction (Contestabile et al., 2003).   
The NO-caspase connection has been an important component of several 
review articles addressing the anti-apoptotic role of NO.  The active sites of almost all 
caspase family members are known to become S-nitrosylated, resulting in loss of 
enzyme function. Interference by NO has also been observed in the pro-apoptotic 
signaling cascade by not allowing caspase processing rather than inhibition of enzyme 




activation events documented in so many instances in association with the pro-
apoptotic role of NO, is still not clear.   
Other anti-apoptotic roles of NO involve the transcriptional up-regulation of 
cytoprotective genes such as Cox-2, CuZn superoxide dismutase, heme-oxygenase-1, 
heat shock protein 70 and manganese superoxide dismutase (Brune et al., 1999).  Most 
of these are downstream of various different transcription factor-coupled pathways, 
and their regulation downstream of NO is associated with attenuation of NO toxicity. 
 
1.3 NO and gene regulation 
The notion of a linear sequence of signaling events – extracellular ligands binding 
to cell surface receptors, activation of specific linear cassettes of signal transduction 
pathways enabling a cell to constantly adapt and coordinate its activities with changes 
in the microenvironment, is seriously challenged by the ligand NO, which freely 
diffuses through cell membranes to reach its targets at different intracellular locations 
and alters signaling networks by redox-sensitive modifications (Pfeilschifter et al., 
2001). The early and rapid mechanisms of NO signaling depend primarily on post-
translational modifications of pre-existing cellular proteins; however, the late phases 
that are required to accommodate the changing micro environment are mediated by 
changes in gene expression (Pfeilschifter et al., 2001).  Table 1 shows a brief summary 
of the transcription factors known to be modulated by NO in various cell types 
(Bogdan, 2001).   
The adaptive long-term regulation occurs mainly at the level of transcription and 
is controlled by transcription factors.  To date, there is no evidence for the existence of 
DNA elements in the promoters of genes which directly respond to NO. In a 




of NO) that selectively bind their cognate sites in the regulatory elements of NO-
responsive genes come together and activate/ repress gene transcription.  Sensitivity of 
various cellular components to the cellular redox status primarily enables NO 
modulation of transcription factors, of the translation or stability of mRNA, or of the 
processing of the primary gene product. Some of the known effects of NO on 
transcription factors are discussed below. 
Nuclear factor κB (NFκB), best known for its stimulatory functions in B cells and 
macrophages, is a hetero dimeric transcription factor, which exists in an inactive state 
in the cytosol, where it is bound to members of the IκB (inhibitor of NFκB)family.  
Activating signals like cytokines or oxygen radicals, lead to IκB kinase (IKK) 
mediated phosphorylation, ubiquitination and proteosomal degradation of IκB, 
allowing the free NFκB to translocate to the nucleus.  NO is known to affect NFκB 
activity in at least four different ways.  Firstly, NO is known to activate signals 
upstream of IκB such as p21ras or IKK-α activity in T lymphocytes and endothelial 
cells, respectively.  NO might scavenge °O2−, thereby reducing the formation of H2O2 
and impeding the action of NFκB, as seen in the NFκB-mediated transcriptional down-
regulation of monocyte chemo attractant protein-1 and macrophage colony stimulation 
factor-1. Thirdly, NO upregulates and stabilizes the expression of IκB-α mRNA and 
protein and promotes the translocation of IκB-α to the nucleus where it prevents NFκB 
interacting with its DNA- binding sites (which mainly accounts for the down-
regulation of vascular cellular adhesion molecule-1 expression, seen in primary 
endothelial cells) (Bogdan, 2001).  Lastly, in cell-free systems, NO inhibits the DNA-
binding activity of NFκB through the S-nitrosylation of a crucial cysteine residue 




activating stimulus applied, and other factors, NO can activate or inhibit NFκB gene 
transcription by interacting with multiple intracellular targets (Bogdan, 2001). 
 
Table 1. Selected examples for the regulatory effect of NO on mammalian 









Activating protein (AP)-1, a heterodimeric transcription factor that belongs to the 
basic leucine zipper family, consists in its most active form of two proto-oncogenic 
products, c-Fos and c-Jun.  It binds to phorbol-ester response elements (TREs), present 
in the regulatory region of many genes.  NO stimulation of sGC and cGMP, through 
G-kinase, is known to increase c-fos and jun-B gene expression.  Modulation of JNK2 
(Jun N-terminal kinase- 2) and JNK2 kinases, protein kinase cascades upstream of AP-
1, has also been observed.  S-glutathionylation of c-Jun at cys-269, has been reported 
to inhibit DNA-binding (Pfeilschifter et al., 2001).  Basal c-Jun/AP-1 activity has also 
been found to be important for counteracting apoptosis induced by low levels of NO 
through regulation of the expression of sgII (gene encoding secretogranin II)  (L. Li, 
per. comm.) and NCAM140 (neural cell adhesion molecule 140) (Feng et al., 2002). 
But at the same time, at toxic concentrations of NO, c-Jun is phosphorylated 
exclusively on Ser-63 in a JNK-dependent manner, which enhances c-Jun/AP-1 
transcriptional activity, counteracts the protective function of basal AP-1, and 
eventually leads to apoptosis in SH-Sy5y cells (Li et al., 2004b).   
NO has also been implicated in the translocation of Nrf2 (nuclear factor-erythroid 
2 related factor) into the nucleus and its enhanced binding (along with small Maf 
proteins) to the antioxidant response element (ARE), found in the promoter of 
NAD(P)H: quinine oxidoreductase1 (Nqo1) and other detoxifying enzymes.  This 
early response to NO, resulting in the transcriptional upregulation of cytoprotective 
genes, is known to counteract NO-induced apoptosis (Dhakshinamoorthy and Porter, 
2004).  
NO destroys ZnS clusters and ejects Zn2+ from various proteins including 
transcription factors that contain Zn-coordinated DNA-binding motifs (‘zinc fingers’).  




causes the loss of in vitro DNA binding capacity, as demonstrated for p53, Sp1, Egr-1, 
the glucocorticoid receptor, Vit D receptor, and retinoid X receptor (Pfeilschifter et al., 
2001).   
In addition, a novel pathway for gene silencing based on the activation of the 
DNA methyltransferase by S-nitrosylation of critical cysteine residues and the 
subsequent modification of the CpG island methylation has been reported (FMR1 
gene, in mouse macrophages) - methylated CpG-dinucleotides favor a repressive 
chromatin structure that impede the promoter binding of transcription activators 
(Pfeilschifter et al., 2001). 
NO has also been implicated in affecting mRNA stability and hence, the gene 
expression status of the cell.  For example, NO-mediated stabilization of the 
transferrin receptor, hemoxygenase-1 and iNOS mRNA itself by a positive feed back 
loop, have been observed (Turpaev and Litvinov, 2004).   
Temporal patterns of NO-mediated cascades of gene expression has been 
observed with both protective and anti-apoptotic implications, or at times both, 
depending on the intensity of the signal (Hemish et al., 2003).  Though much work has 
been put into analyzing the transcription machinery reacting to NO in mammalian 
cells, there is still no clear picture; in fact contradictory results for even the same 
transcription factors have been observed.  This could be a result of the use of different 
sources of NO (specifically, this could include the use of chemical compounds that 
preferentially release one of the many RNIs; along with common donors like SNP that 
also release trace amounts of ferricyanide), or different concentrations of NO, the use 
of cell free versus cell-containing systems, or of different cell types, or even variations 




Regulation of apoptosis is known to occur at multiple levels in three-dimensional 
signal transduction pathways and many different incoming signals including NO 
initiate a varied broad spectrum of responses, regulating the initiation of apoptosis or 
its inhibition.  There is a huge scope to decipher and better understand the details of 
the transmission of pro- and anti-apoptotic signals by NO that ultimately determine the 
fate of the cell.  
 
1.4 FOXOs 
1.4.1 The forkhead family 
Initial investigations leading to identification of Forkhead transcription factors 
as key effectors of PI3K-PKB signaling began in the nematode worm Caenorhabditis 
elegans. When environmental conditions are adverse, these worms can enter a so-
called Dauer or "non-aging" larval stage where they can survive for months. This state 
of developmental arrest is associated with reduced metabolic activity and increased 
resistance to oxidative stress.  The process is regulated by a neuroendocrine pathway 
that has been extensively studied by genetic analysis (Birkenkamp and Coffer, 2003a).  
Regulation of a C. elegans PI3K (age-1) signal transduction pathway was found to be 
essential in modulation of dauer entry. Critically, mutations in the Forkhead 
transcription factor DAF-16 were found to completely suppress the dauer arrest, 
metabolic shift and longevity observed in age-1 mutants (Lee et al., 2003). DAF-16 
was found to be negatively regulated by DAF-2, an insulin receptor-like protein, and 
further epistatic analysis implicated PI-3K, PTEN, PDK-1 and PKB/ Akt in the DAF-2 
regulation of DAF-16.  Several consensus sequences for phosphorylation by PKB/ Akt 




The forkhead family of transcription factors comprises more than 100 members 
in species ranging from yeast to humans.  About 40 different forkheads have been 
identified till date in mammalian cells.  Mammalian homologues of the Forkhead 
superfamily are characterized by the presence of a conserved 110 amino acid DNA 
binding domain, that was shown to form a typical butterfly-shaped structure made up 
of three tightly packed N-terminal -helices, three ß-sheets, and two loop regions 
located at the C-terminal end that shape the wings of the structure called the "forkhead" 
domain or "winged helix" domain (Burgering and Medema, 2003).  
Recently, a new nomenclature for these factors has been adopted, and they are 
now denoted Forkhead box (FOX) factors. This superfamily has been classified into 
17 sub-families ranging from FOXA to FOXQ, based on phylogenetic analysis. The 
Forkhead box class O (FOXO) factors are a subclass within the superfamily.  This sub- 
family of proteins is the only one that is known to be regulated by the PKB/Akt 
pathway and also share the most homology to the C.elegans’ DAF-16 protein.  Three 
mammalian proteins belong to this subfamily: forkhead in rhabdomyosarcoma 
(FKHR), FKHR-like 1 (FKHRL1), and acute-lymphocytic-leukemia-1 fused gene 
from chromosome X (AFX). FKHR is now known as FOXO1, FKHRL1 is known as 
FOXO3a, and AFX is known as FOXO4 (Burgering and Medema, 2003).  FOXO4 is 
studied in my thesis. 
These three FOXO proteins interact preferentially with a core consensus 
recognition motif 5'-TTGTTTAC-3', although the residues flanking this core 
contribute to some DNA binding specificity. Interestingly, the FOXO factors were 
initially identified at chromosomal breakpoints in several human tumors. For instance, 




leukemia gives rise to a fusion between the coding region of the mixed-lineage 
leukemia (MLL) gene, a thritorax-related transcription factor and FOXO4 (Borkhardt 
et al., 1997).  These genetic alterations of FOXOs in human cancers strongly suggested 
that they may play a role in the regulation of proliferation, survival or differentiation in 
higher organisms.   
The tissue expression pattern of the FOXO proteins is similar.  Given the role 
of FOXOs in apoptosis and stress responses, most cell types express one or more of 
the FOXO isoforms.  FKHR expression is enriched in adipose tissue, liver and 
thymocytes, while, FKHRL1 and AFX are observed to be expressed at higher levels in 
post-mitotic neurons in the brain and  muscle tissues, respectively (Tran et al., 2003). 
The physiological functions of FOXO proteins, as deduced from loss/ gain of 
function studies in transgenic and knock out mice, are complex.  Mice lacking the 
three FOXO iso-forms display remarkably different phenotypes.  But most transgenics 
do share a defective insulin signaling pathway as a common aberration– FOXO 
ablation in mice can rescue diabetes caused due to pancreatic β cell failure while, on 
the other hand, FOXO over-expression sensitizes mice to diabetes.  Insulin signaling, 
being key to regulation of glucose uptake and metabolism, also affects the life span of 
these animals (Accili and Arden, 2004). 
1.4.2 Forkhead regulation 
The FOXO factors are phosphorylated in vivo on multiple threonine and serine 
residues. In the absence of PKB activity, the FOXO members are predominantly 
nuclear and thus presumed to be active; however, PKB-mediated phosphorylation 




Phosphoinositide 3-kinases (PI3Ks) are activated by several proteins including 
G-proteins and tyrosine kinases, downstream of various growth factor and other 
signals. Recruitment of PI3K to membrane receptors relocates PI3K to its lipid 
substrates on the plasma membrane where it phosphorylates the 3’-OH group of the 
inositol ring of phosphatidylinositol to generate the phosphoinositide phosphates PIP2 
and PIP3. These two signalling molecules trigger downstream serine/ threonine 
kinases including 3’-phosphoinositide dependent kinase-1 (PDK-1) and protein kinase 
B (PKB).  The latter is also known as Akt, a member of the AGC family (cAMP-
dependent protein kinase/protein kinase G/protein kinase C extended family) of 
protein kinases that is catalytically activated through recruitment and phosphorylation 
by PDK-1. Activated PKB detaches from the plasma membrane and translocates to the 
cytosol and nucleus where it phosphorylates serine or threonine residues within a PKB 







Figure 1.  A schematic representation of FOXO transcription factors and their 
potential sites of phosphorylation. 
One such candidate is the FOXO family of proteins.  FOXOs are known to be 
phosphorylated on multiple sites (the implicated serines and threonines are denoted as 
DBD NLS NES 
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Ss and Ts on Fig. 1).  Three of these, an N terminal threonine and two serines (T1, S1, 
and S2) lie within a consensus motif for phosphorylation by PKB.  PKB-mediated 
phosphorylation therein, induces the binding of 14-3-3 protein (which harbours a NES 
- nuclear export signal) to the FOXO proteins in the nucleus, which results in the 
release of the FOXO protein from the DNA and subsequent translocation from the 
nucleus to the cytoplasm (Zheng et al., 2002).  Nuclear export of FOXO members is 
sensitive to leptomycin B treatment, indicating that export depends on Crm1 
(chromosomal region maintenance-1) too (Kops et al., 1999). All three FOXO 
members also harbour a putative NES. Deletion of the putative NES clearly affects the 
nuclear export of FOXO4, yet surprisingly does not affect Crm1 binding (Brownawell 
et al., 2001). In addition, phosphorylation does not significantly modulate the binding 
between FOXO proteins and Crm1. FOXO proteins also contain a sequence that 
conforms to a non-classical NLS.  This NLS consists of three arginine residues present 
in the forkhead domain C- terminus, and three lysine residues located 19 residues 
further downstream.  The S1 phosphorylation site is present within this motif and the 
basic nature of the NLS is perturbed by the negative charge introduced by the 
phosphorylation of S1.  The phosphorylated serine thus hinders the NLS function 
sterically.       
As indicated in Fig. 1, not all phosphorylation of FOXO members occurs as a 
result of PI3K–PKB signaling. For example, it was reported that serum and 
glucocorticoid-inducible kinase (SGK) can also phosphorylate T1 and S2 of FOXO3a 
(Figure 1). Like PKB, SGK is a member of the AGC-kinase family, and PDK1 (3’-
phosphoinositide dependent kinase-1) appears to be responsible for T-loop 
phosphorylation and activation of SGK, just as it phosphorylates PKB. Thus, in PI3K-




independently of PKB to increase the phosphorylation of these sites (Van Der Heide et 
al., 2004). 
The S5 site can be phosphorylated by dual-specificity tyrosine-phosphorylated 
and -regulated kinase 1A (DYRK1a) (Fig. 1). Although phosphorylation at this residue 
in FOXO1 affects nuclear localization, DYRK1a itself appears to be constitutively 
active, so the relevance of this phosphorylation in regulated shuttling remains unclear.  
Casein kinase 1 has been shown to phosphorylate S3 and S4, again the implications 
are unclear (Kops et al., 1999). 
Finally, a role for signaling by the small GTPase Ras has also been suggested 
in the regulation of FOXO4. Like PI3K, Ras is activated following treatment of cells 
with insulin. Activated Ras can stimulate different downstream signalling cascades, 
one of which proceeds when active Ras binds the exchange factor (RalGEF) for 
another small GTPase, Ral. In this way, RalGEF binding to Ras results in Ral 
activation. The phosphorylation site of AFX regulated by Ras–Ral signalling has been 
identified and consists of two adjacent threonines (T3 and T4; Fig. 1). Mutational 
analysis shows that phosphorylation of these residues is essential for AFX activity 
(Burgering and Kops, 2002). 
PKB and other kinase mediated phosphorylation of FOXO can regulate its 
transcriptional activity in several ways other than merely regulating their nuclear 
import or export. First, the binding of the 14-3-3 protein to FOXO proteins (which is 
induced by PKB phosphorylation) has been suggested to inhibit their binding to DNA 
(Daly et al., 2004).  It is to be noted here that the S1 phosphorylation site is also part 
of the DNA binding region of the FOXO proteins and any phosphorylation event 




Secondly, phosphorylation might affect the stability of the FOXO proteins, though 
FOXO4 is known to be relatively stable, with a low turnover.  Lastly, phosphorylation 
might disturb FOXO interaction with various cofactors that are essential to activate 
transcription. A handful of proteins are known to interact with FOXOs and help 
mediate gene expression profile changes as well as determine which target genes are 
regulated after specific signals.  A recent study described the histone acetylase 
p300/CREB-binding protein (CBP) as a co-activator for FOXO1 (Kops et al., 1999). 
Furthermore, FOXO1 was shown to interact with both steroid and non-steroid nuclear 
receptors (Li et al., 2003).  FOXO1 differentially regulated the transactivation 
mediated by these different nuclear receptors, either as a co-activator or co-repressor, 
depending on the receptor and cell type (Zhao et al., 2001).  Roles for FOXOs in 
modulating HNF-4 (hepatocyte nuclear factor- 3) and STAT3-mediated transcription 
have been reported recently (Hirota et al., 2003; Kortylewski et al., 2003). 
Interestingly, FOXO1 increased STAT3- but not STAT5-mediated transcription, 
demonstrating specificity for the STAT transcription factor iso-forms. However, it 
remains to be determined whether (and how) phosphorylation modulates the 
interaction between FOXO members and all its other interacting partners. 
1.4.3 Physiological roles of FOXOs 
FOXO mediated transcriptional control of key metabolic enzymes such as IGF- 
binding proteins, glucose-6-phosphatase and phospho-enol-pyruvate carboxy kinase 
(PEPCK) is well documented (Nakae et al., 2001).  The other transcriptional targets 
that mediate the direct effects of FOXO activity on cell survival, cell cycle control, 





Regulation of Apoptosis:  
The death agonist Fas ligand (FasL) has been identified as a mediator of 
FOXO-induced cell death (Brunet et al., 1999).  Up-regulation of the pro-apoptotic 
Bcl-2 family member Bim plays a role in FOXO-dependent cell death upon cytokine 
withdrawal in a number of hematopoietic cell types (Sunters et al., 2003; Tran et al., 
2003).  TRAIL, a pro-apoptotic member of the TNF family, has also been shown to be 
under the transcriptional contol of FOXOs (Ghaffari et al., 2003; Modur et al., 2002).   
Cell Cycle Regulation: 
FOXO activity mediates G1 cell cycle arrest at least in part by inducing 
expression of the cell cycle inhibitor p27kip1. p27kip1 acts to block the activity of the 
cyclin E – CDK2 (cyclin-dependent kinase 2) complex, thereby preventing entry into 
S phase (Coffer, 2003; Zheng et al., 2002).  The suppression of the D-type cyclins has 
also been implicated in FOXO-mediated growth arrest. As cells progress through G1, 
D-type cyclins are synthesized and form a complex with their corresponding catalytic 
partners CDK4 and CDK6. These cyclinD-CDK complexes function to inactivate the 
retinoblastoma tumor suppressor protein, permitting progression into the S phase 
(Schmidt et al., 2002; Tran et al., 2003).  
FOXO activity has also been observed to induce cells to exit the cell cycle and 
enter a non-dividing, quiescent state (G0). This switch is characterized by reduced 
protein synthesis and increased abundance of the retinoblastoma family protein p130 
which itself appears to represent a direct target of FOXO.  Although the FOXO-
induced increase in p130 does not affect cyclin E-dependent kinase activity and is 




to be required for the FOXO-induced decrease in protein synthesis that has been 
correlated with cellular quiescence. FOXO thus acts to block cell cycle progression 
prior to DNA synthesis and to induce cellular quiescence via a variety of target genes 
(Kops et al., 2002b). 
Human cyclin B and polo-like kinase (PLK), two genes whose products have 
critical roles in G2-M phase progression, have also been found to be regulated by 
FOXOs at the transcriptional level (Birkenkamp and Coffer, 2003b).  Cyclin B levels 
rise in G2 phase and allow for entry into and progression through M phase, whereas 
exit from mitosis is promoted by cyclin B ubiquitination and degradation. PLK 
controls this ubiquitination process by regulating the anaphase-promoting complex, a 
ubiquitin ligase that causes cyclin B degradation and M phase completion. These 
results further emphasize the key role that FOXO family members play in controlling 
mitosis by regulating the expression of a set of genes that act as crucial mediators of M 
phase progression. 
Thus, in addition to their roles as mediators of apoptosis, FOXO factors 
regulate cell proliferation at multiple phases of the cell cycle. Surprisingly, FOXO 
activity appears to exert opposing effects at different points in the cell cycle; under 
normal physiological conditions, FOXO family members regulate the expression of 
genes such as cyclin B and PLK that promote progression through M phase, whereas 
ectopic FOXO expression can act to arrest cells in G1 and G2. The G1-S and G2-M 
transitions represent important sites of checkpoint regulation by the cell to ensure 
replicative fidelity, raising the possibility that at these critical checkpoints, FOXO 
factors may sense and act to coordinate cellular responses to DNA damage or other 





Foxos have been implicated in a variety of stress responses ranging from 
antioxidant defense to DNA repair.  They have been shown to control the expression 
of antioxidant enzymes manganese superoxide (MnSOD) (Kops et al., 2002a) and 
catalase.  MnSOD can convert °O2−  into H2O2, and catalase can convert H2O2 into 
H2O and O2, thereby catalyzing a simple linear chain of events that ultimately protects 
cells from superoxide.  These events in particular are associated with forkhead 
mediated induction of quiescence in cells and reflect in the increased resistance shown 
by cells to glucose starvation, especially in the absence of active PKB/ Akt.  
Gadd45-α (growth arrest and DNA damage 45-α) has also been discovered as a 
FOXO target that functions in G2 arrest. Gadd45-α is up-regulated under conditions of 
stress or growth factor deprivation and it contributes to G2 arrest by preventing the 
interaction of the cyclin-dependent kinase cdc2 with cyclin B (Burgering and 









Figure. 2  A summary of known transcriptional targets of FOXOs, classified 
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Apoptotic stimuli are known to activate both pro-death and pro-survival 
molecules.  The seemingly contradictory implication of the up-regulation of both Bim 
and MnSOD, by FKHRL1 in GM-701 fibroblast cells, after growth factor deprivation, 
is a relevant example in this case (Liu et al., 2005).  Other studies have implicated 
both up and down regulation of Cu/ ZnSOD, Bcl-2, Bcl-XL, cytochrome c, at least 
partially due to direct FOXO regulation (confirmed by the absence of such regulation 
in FOXO dominant-negative constructs or primary cells from knockout animals). In 
cells of hematopoietic origin, mere activation of a FOXO factor is sufficient to activate 
a variety of pro-apoptotic genes and to trigger apoptosis. In contrast, in most other cell 
types, activation of FOXOs blocks cellular proliferation and drives cells into a 
quiescent state. In such cell types, FOXO factors also provide the protective 
mechanisms that are required to adapt to the altered metabolic state of quiescent cells. 
Thus, FOXO factors can determine the fate of a cell, can initiate long-term survival in 
a quiescent state or programmed cell death (Burgering and Medema, 2003). It is in this 
context that it will be interesting to study the relationships of FOXOs and NO, another 
important molecule that is known to regulate both death and survival.   
 
1.5 C/EBP HOMOLOGY PROTEIN (CHOP) 
1.5.1 Endoplasmic Reticulum (ER) stress 
Several experiments have suggested the existence of p53-independent 
signaling pathways operating during NO-mediated apoptosis.  Islet cells lacking poly 
ADP-ribose polymerase (PARP) and p53-deficient microglial cells, still undergo 




endoplasmic reticulum (ER) stress pathway is one of the contenders for a p53-
independent signaling pathway. 
The ER plays several important roles in the folding, export, and processing of 
newly synthesized proteins.  Exposure of cells to stress results in protein unfolding and 
impairment of cellular processes. When such stress results in the transcriptional 
activation of genes harboring ER stress response elements within their promoters that 
help alleviate the pressure on the ER, pre-emptive apoptosis occurs in cells. The 
collective response is referred to as the ER stress response pathway (schematically 
represented in Fig. 3). 
A variety of triggers including agents such as tunicamycin, which blocks 
protein glycosylation, brefeldin A, which blocks ER-Golgi transport, and general 
inhibitors like dithiothreitol that block formation of disulphide bonds and affect 
protein folding can result in the accumulation of unfolded proteins in the ER lumen 
(Rao et al., 2004).  These then bind to Bip/ Grp78 and competitively disrupt the 
interaction between Bip/ Grp78 and Ire-α (inositol- requiring).  The free Ire-α cleaves 
28S rRNA and inhibits translation in the cell.  ER stress also results in the cleavage of 
ATF-6 (activating transcription factor-6).  Its cytosolic domain translocates to the 
nucleus, where it functions as a basic leucine zipper transcription factor of the 
ATF/CREB family, leading to the activation of genes possessing an ER stress element 
(ERSE) in the promoter region (Gotoh et al., 2002).  Such genes include chaperones 
such as Bip/ Grp78 and calreticulin, other mitochondrial stress proteins like mtDnaJ 
and ClpP (caseinolytic protease P) and transcription factors such as CHOP (Ferri and 





Figure 3.  Schematic representation of the ER stress response in mammalian cells 
(Ferri and Kroemer, 2001). 
 
 
1.5.2 CHOP in ER stress 
CHOP (also called GADD153 - growth arrest DNA damage 153) is a bZIP 
transcription factor and is a member of the C/EBP family.  The GADD genes are a 
group of genes that are induced by genotoxic stress and growth arrest signals. There 
are three distinct GADD genes, GADD34, GADD45 and GADD153, but there is no 
similarity among them. C/EBPs form a family of transcription factors that regulate a 
variety of genes involved in a broad range of physiological processes, including 
immune functions as well as cell differentiation and proliferation (Oh-Hashi et al., 
2001). To date, six distinct members of the C/EBP family have been identified. CHOP 
protein is composed of two known functional domains, an N-terminal transcriptional 
activation domain and a C-terminal basic-leucine zipper (bZIP) domain consisting of a 




motif (Oyadomari and Mori, 2004).  CHOP negatively modulates the C/EBP 
(CCAAT/enhancer-binding protein) transcription factors by heterodimerizing with 
members of the family.  These stable heterodimers do not bind to the classical C/EBP 
sites and thus inhibit the expression of genes that contain the consensus element in 
their promoter regions (Igase et al., 2001). There is no evidence for CHOP 
homodimers.  However, some novel specific DNA sequences have also been identified 
as possible recognition elements for the heterodimers as well as monomeric CHOP 
(Ubeda et al., 1996).   
CHOP is known to be up-regulated by a variety of stress responses including 
hypoxia, growth arrest, DNA damage, amino acid and glucose deprivation, apart from 
exposure to known direct ER stressors.  A consensus ERSE has been identified in 
CHOP and is known to be involved in p50ATF6-mediated expression of CHOP 
mRNA (Ubeda and Habener, 2000).   
Further proof that CHOP is induced by ER stress and plays a role in growth 
arrest and cell death comes from the fact that the unfolded protein response and the 
induction of CHOP can be attenuated by the over-expression of an ER chaperone, 
BiP/Grp78 (Wang et al., 1996). CHOP is also induced by activation of Ire1α or Ire1β, 
ATF6, and PERK, all of which are upstream mediators of the ER stress pathway (Fig. 
3).  Targeted disruption of the CHOP gene in mice, protected cells against ER stress-
induced apoptosis, as was seen in the case of protection against tunicamycin-induced 
apoptosis in proximal renal tubular epithelia (Oyadomari et al., 2001). 
1.5.3 NO, ER stress and CHOP 
What are the possible mediators of the cell death pathway between NO and ER 




numerous proteins and affect ZnS clusters and disulphide bonding - all of which 
perturb the tertiary structure of proteins, possibly initiating the unfolded protein 
response.  Oyadomari et al (2001) also reported that ER Ca2+ stores could be a 
previously unrecognized target of NO. NO was shown to deplete ER Ca2+, cause ER 
stress and apoptosis through the ER stress pathway in pancreatic-β cells. Over-
expression of calreticulin increased the Ca2+ content of the ER and protected cells 
against NO-mediated apoptosis. Molecular components of ER Ca2+ homeostasis 
including pumps for Ca2+ uptake (SERCAs), Ca2+-binding proteins, and channels for 
Ca2+ release, inositol 1,4,5-triphosphate receptors and ryanodine receptors are the 
possible target molecules of NO in NO-induced depletion of ER Ca2+ (Oyadomari et 
al., 2001). 
CHOP also undergoes stress-inducible phosphorylation by a p38-type MAP 
kinase and this phosphorylation event is known to further enhance the transcriptional 
activation potential of the protein (Oh-Hashi et al., 2001).   
Target genes of CHOP, designated as DOCs (downstream of CHOP) are just 
beginning to be identified.  Wang et al (1998) found candidate target genes of the 
CHOP protein using representational difference analysis.  However none of these have 
been shown to be directly involved in the process of programmed cell death.  A novel 
form of carbonic anhydrase V1, identified as one of the DOCs, may promote apoptosis 
indirectly by increasing intracellular proton concentrations (Wang et al., 1998).  
Recently CHOP expression has also been implicated in down-regulation of Bcl-2 
expression, depletion of cellular glutathione, and exaggerated production of reactive 
oxygen species (Kawahara et al., 2001).  Bcl-2 antagonizes CHOP-induced apoptosis 
and sensitization to ER stress, further confirming its important role in effecting CHOP 




Bcl-2 can be expected to facilitate MMP (mitochondrial membrane potential) 
induction as ER stress has been observed to finally trigger the induction (Reimertz et 




The role of CHOP as an ER stress response element is well established, though 
details of how it mediates cell death through its transcriptional activation capability is 
still not clear. NO, on the other hand, has also been implicated in causing apoptosis 
through multiple pathways, with ER stress (through the unfolded protein response 
pathway) being one of them.  But any precise role of CHOP in NO-mediated cell 
death, specifically, is not well documented.  Here I intend to begin my investigation 
with the observation of (any) induction of CHOP after NO treatment of neuroblastoma 
cells.  I also intend to follow up on its physiological relevance, with reference to 
sensitivity to NO-mediated cell death, preferably, solely transmitted through CHOP 
and its transcriptional activity.  The elucidation of mechanisms of how CHOP 
regulates cell death and identification of its transcriptional targets relevant to apoptosis 











CHAPTER 2  -  MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Common reagents 
A list of some of the common reagents used in this study and their source: 
Description      Source 
Media preparation components  Difco laboratories 
Laboratory chemicals    Sigma 
Deta-NO     Sigma 
SNP      Sigma 
Okadaic acid     Roche 
Insulin      Sigma 
Hygromycin     Clontech Laboratories 
Geneticin (Neomycin)   Invitrogen 
Metaphor agarose    Cambrex Bioscience 
Culture dishes     Nunc 
1 Kb DNA ladder     Promega 
10 bp DNA ladder    Invitrogen 
Broad range protein ladder   Invitrogen 
pcDNA3.1/ V5-His TOPO TA kit  Invitrogen 
pcDNA4/ TO vector    Invitrogen 
pGL3 (with SV-40 promoter)   Promega 
pRl-Tk (Renilla) vector   Promega 
Blasticidin      Invitrogen 
Zeocin      Invitrogen 
Stripping buffer    Pierce 
2.1.2 Antibodies 







Antibody     Source 
AFX      Cell Signalling 
FKHR      Cell Signalling 
FKHRL1     Santa Cruz Biotechnology 
Phospho- AFX (Ser 197)   Cell Signalling 
Phospho- FKHR (Ser256)   Cell Signalling 
Phospho-FKHRL1(Thr32)   Santa Cruz Biotechnology 
CHOP      Santa Cruz Biotechnology 
Bcl-2      Santa Cruz Biotechnology 
V5      Invitrogen 
Myc      Invitrogen 
Caspase-3     Transduction Laboratories 
PARP      BD Pharmingen 
Anti- rabbit, HRP conjugated   Chemicon International 
Anti- mouse, HRP conjugated  Chemicon International 
Anti- goat, HRP conjugated   Chemicon International 
Fluorescent secondary antibodies  Alexa Chemicals 
2.1.3 Primers  
Oligonucleotides (synthesized by Research Biolabs, Singapore) used in this 
study, are listed below (F stands for forward and R for reverse, primers): 
Oligonucleotide  Sequence (5’ to 3’) 
AFX orf F       CCA CGT ATG GAT CCG GGG AAT 
AFX orf R       GGG ATC TGG CTC AAA GTT GAA 
 
AFX GFP F       CCC AAG CTT CCA CGT ATG GAT CCG GGG AAT  
AFX GFP R        CGG GGT ACC GGG ATC TGG CTC AAA GTT GAA 
 
AFX orf p4 F      CCC AAG CTT CCA CGT ATG GAT CCG GGG AAT 
AFX orf p4 R      CCG CTC GAG TCA GGG ATC TGG CTC AAA GTT 
 
AFX S197A F   CCG GGC CGC CGC CAT GGA TAG CA  
AFX S197A R   TGC TAT CCA TGG CGG CGG CCC GG  
 
Gadd 153 F   ACT GCA GAG ATG GCA GCT GAG TCA T 






IRS 3X XmaI F  CCG GGC AAA ACA AAC TTA TTT TGA AGC AAA ACA  
ACT TAT TTT GAA GCA AAA CAA ACT TAT TTT GAA 
IRS 3X XhoI R TCG ATT CAA AAT AAG TTT GTT TTG CTT CAA AAT AAG 
TTT GTT TTG CTT CAA AAT AAG TTT GTT TTG C 
 
Mut IRS 3X XmaI F  CCG GGC AAA AGA AAC TTC TTT TGA AGC AAA AGA A 
AC TTC TTT TGA AGC AAA AGA AAC TTC TTT TGA A 
Mut IRS 3X XhoI R TCG ATT CAA AAG AAG TTT CTT TTG CTT CAA AAG AAG 
TTT CTT TTG CTT CAA AAG AAG TTT CTT TTG C 
 
FKHRL1 orf F  GGC GGC GAA GAT GGC AGA GGC ACC G 
FKHRL1 orf R  GCC TGG CAC CCA GCT CTG AGA TGA G 
 
FKHR N F    CAC AGC AAG TTC ATT CGT GTG CAG A 
FKHR N R   GGA GAG TCA GAA GTC AGC AAC TCC T 
 
BimEL F   TGA TGT AAG TTC TGA GTG TG 
BimEL R   GTG TCA AAA GAG AAA TAC CC 
 
CyclinD1  F   CGA GGA GCT GCT GCA AAT GG  
CyclinD1 R   GGT ATC AAA ATG CTC CGG AGA GG 
 
Trail S F   TGC TGG CAA GTC AAG TGG CA 
Trail S R   GCC AAC TAA AAA GGC CCC GA 
 
CyclinD2 F   AGC AGC GGG AGA AGC TGT CTC TGA TCC 
CyclinD2 R   ATG GAC GCG TCT CTC TCT TTC GGC C 
 
p27 F    CGG GAG AAA GAT GTC AAA CGT GCG A 
p27 R    CGT TTG ACG TCT TCT GAG GCC AGG C 
 
p130 F    GGG GTG CGC TAT GCC GTC GGG AGG T 
p130 R    TCC CAG GTT CTA GAA ACC CAG TGA G 
  
Trail F    TGA CAG GAT CAT GGC TAT GAT GGA G 
Trail R    GCC AAC TAA AAA GGC CCC GAA AAA A 
 
Bcl6 F    TGA AGA CAA AAT GGC CTC GCC GGC T 
Bcl6 R    CAG GCA TCC GGA CAT CCC GAA ACT C 
  
B actin F   ATG GAT GAT GAT ATC GCC GCG CTC G 
B actin R   GAA GCA TTT GCG GTG GAC GAT GGA G 
 
The underlined nucleotides indicate the introduction of a base pair change, as 






2.1.4 Stable cell lines 
List of SH-Sy5y cell lines selected for stable expression of the constructs 
mentioned alongwith:  
Name    Description 
p3.1-AFX AFX- pcDNA3.1 transfected SH-Sy5y cells; Neomycin 
resistant. 
 
p3.1 pcDNA3.1 transfected SH-Sy5y cells (vector control); 
Neomycin resistant. 
 
Tet-12 pcDNA6 (expressing tetracyclin repressor) transfected 
SH-Sy5y cells; Blasticidin resistant; kindly provided by 
Dr. Chris Redfern, University of Newcastle, UK 
 
p4- TO pcDNA4- TO transfected Tet-12 cells (vector control); 
Blasticidin and Zeocin resistant. 
 
p4- AFX AFX-pcDNA4 transfected Tet-12 cells; Blasticidin and 
Zeocin resistant. 
 
AFX- EGFP AFX-EGFP transfected SH-Sy5y cells; Hygromycin 
resistant. 
 
EGFP EGFP (N2) transfected SH-Sy5y cells (vector control); 
Hygromycin resistant. 
 
p4- S CHOP CHOP-pcDNA4 transfected Tet-12 cells; Blasticidin and 
Zeocin resistant. 
 
p4- AS CHOP Anti- sense CHOP-pcDNA4 transfected Tet-12 cells; 
Blasticidin and Zeocin resistant. 
 
 
2.2 Mammalian cell culture 
2.2.1 Cell lines, passaging and treatments 
Human neuroblastoma cell line SH-Sy5y and mouse fibroblast cell line NIH-
3T3 were maintained in Dulbecco’s modified Eagle’s medium (Gibco BRL, USA; 
4.5g/l glucose), supplemented with 10% (v/v) heat-inactivated fetal calf serum 
(Hyclone Laboratories, USA), 100u/ml penicillin and 0.1mg/ml streptomycin (both 




37°C incubator, under partial CO2 pressure of 5%.   0.125% Trypsin- Versene and 
PBS were used during passages and washes.  Cells were passaged (1 flask into 4) 
every 4-5 days. 
2’, 2’(hydroxynitrosohydrazono) bis-ethanamine (Deta-NO)  and sodium 
nitroprusside (SNP) were the two extrinsic NO donors that were used in this study.  
Deta-NO is a relatively pure NO donor releasing only NO and the free amine, 
diethylenetriamine (Borutaite and Brown, 2003).  While NO delivery is almost 
instantaneous at acidic pH, the release of NO follows much slower kinetics at 
physiological pH.  Deta-NO is also easily soluble in water and is stable (with a half 
life around 30 hours).  SNP, on the other hand, requires enzymatic bio-activation or 
reaction with thiols.  Its NO release is accompanied by the release of H2O2, cyanide, 
ferrocyanide and ferricyanide (Kimura et al., 2002). 
For NO treatment of cells, 1.5 and 2 mM concentrations of Deta-NO and SNP, 
respectively, were found to cause apoptosis starting 12 hours (Feng et al., 2002), in 
SH-Sy5y cells and hence, were the preferred concentrations for treatments facilitating 
the observation of the effects of inhibitory levels of NO in mammalian cells. 
NIH-3T3 cells were used in parallel as positive controls, by exploiting the AFX 
S-197 phosphorylation that is known to occur post insulin treatment, through the 
activation of PI-3 kinase and PKB (Guo et al., 1999).  Cells were serum starved for 24 
hours and subsequently treated with 1ug/ ml of insulin for 30 minutes.  
Immunoflourescense or protein analysis by western blotting was done to show the 







2.2.2 Freezing and thawing of cells 
70-80% confluent cells were trypsinised, centrifuged at 1000 rpm, for 5 min, at 
4°C, washed with PBS and resuspended in freezing media – 10% (v/v) DMSO in heat- 
inactivated FCS. In order to prevent the formation of intra cellular crystals, the 
aliquots were frozen in ethanol, and subsequently transferred to liquid nitrogen for 
long-term storage.  Recovery involved rapid thawing of the vials and immediate re-
suspension in flasks holding pre-warmed culture media. 
2.2.3 Transient transfection 
1ug of plasmid DNA was transfected in 6-well plates of 60-70% confluent 
cells using Lipofectin (Life Technologies Inc, USA).  Up to 5ul of the lipofectin 
reagent was mixed with the plasmid DNA in 200ul of Opti-MEM reduced serum 
medium (Invitrogen, Carlsbad, CA), and left at room temperature for up to 30 minutes 
to allow DNA-liposome complexes to form.   Cells were washed once with Opti-MEM 
media before being over-laid with 2 ml of the media containing the DNA- lipofectin 
mixture. 
The liposome- DNA mix was incubated with cells for 12-24 hours before the 
cells were treated and analyzed using appropriate protocols for reporter assays, 
western blots, etc.  
2.2.4 Generation of stable cell lines 
Transfection was carried out as above.  12 hours post- transfection, neomycin 
(Invitrogen, Carlsbad, CA) or hygromycin (Sigma Chemicals, St. Louis, MO) 
containing media was added to the cells, at concentrations of 600 and 100ug/ml, 
respectively.  The media was refreshed at 48 hour intervals, for up to 10 days, when 
colonies of resistant cells begin to be seen on the plate.  These are then isolated by 




single cells in separate wells.  These were then progressively cultured into bigger 
flasks, and then analyzed for expression of the desired protein, through western 
blotting.  Confirmed clones were maintained at 200 ug/ml and 50 ug/ ml neomycin or 
hygromycin concentrations, respectively.   
Stable clones with pcDNA4 vectors expressing the protein of interest (AFX 
and CHOP), were made by transfection of the plasmid DNA in Tet-12 background cell 
lines, which in turn, is a stable cell line selected for expression of the Tetracyclin 
repressor protein (by stable integration of the pcDNA6- TetR construct).  Tet-12 cells 
were maintained in 5 ug/ml Blasticidin (Invitrogen, Carlsbad, CA) containing culture 
media. Subsequent selection for pcDNA4- AFX/ CHOP expressing constructs was 
done by selection for growth in media containing an additional antibiotic - 250 ug/ml 
Zeocin (Invitrogen, Carlsbad, CA).  1 ug/ml of tet (Sigma Chemicals, St. Louis, MO) 
was used to induce the expression of the protein of interest, over a 4-24 hour period.  
The expression levels were checked using western blots before further experiments 
involving the AFX/ CHOP over-expressing cell lines were set up. 
2.2.5 Preparation of whole cell extracts 
Cells were washed with cold PBS and trypsinised.  Pelleted cells were then 
lysed in lysis buffer [50mM HEPES, 150 mM NaCl, 1mM EDTA and 1% NP-40 with 
1 protease tablet (Complete, Roche) dissolved in 30 ml of the buffer] by placing on 
ice, for up to 30 minutes.  The mixture was then centrifuged, the supernatant separated 
and the protein content quantitated by Bradford’s assay before subsequent use. 
2.2.6 Preparation of nuclear extracts 
The nuclear extraction kit from Panomics Inc. (Redwood City, CA) was used 
to isolate the nuclear fractions of mammalian cells.  Briefly, pelleted mammalian cells 




nuclei were separated by centrifugation and the nuclear proteins were released by 
vigorous shaking during an overnight incubation in the nuclear lysis buffer (provided 
as part of the kit).  The debris was pelleted and removed, and the nuclear proteins 
quantitated before use.    
2.2.7 RNA extraction 
80 cm2 flasks containing 70-80% confluent cells were homogenized in 1ml of Tri 
reagent (Molecular Research Centre, USA).  The lysate was passed several times 
through a pipette and stored at room temperature for 5 min, to completely dissociate 
nucleoprotein complexes. 200ul of chloroform was then added and the mixture 
thoroughly shaken, before centrifugation at 12000g for 15 minutes.  The upper 
aqueous phase, holding the RNA exclusively, was separated with care from the 
phenol-chloroform phase and the interphase, holding the protein- cell debris and DNA, 
respectively.  500ul of isopropanol was added to the precipitate and stored at room 
temperature for 5 minutes and centrifuged at 12000g for 8 minutes, to precipitate the 
RNA.  The white-pellet like RNA precipitate was then washed with 75% ethanol, air-
dried and dissolved in RNase-free water, and quantitated before use.   
 
2.3 DNA methodology  
2.3.1 Plasmid constructs 
List of plasmids, constructed and used in this study: 
Construct    Description 
AFX- pcDNA3.1 Full length AFX cDNA cloned into pcDNA3.1 vector by 
TA cloning. 
 
AFX- pcDNA4 Full length AFX cDNA cloned into pcDNA4 vector as a 
HindIII- XhoI fragment. 
 





AFX- EGFP Full length AFX cDNA cloned into EGFP N3 vector as 
a HindIII- KpnI fragment. 
 
3X IRS- pGL3 3 consecutive copies of the forkhead consensus sequence 
from the IRS promoter cloned into pGL3 vector as an 
NheI- XhoI fragment. 
 
Mutant 3X IRS- pGL3 The above sequence cloned into pGL3 vector as an 




The PCR reactions were performed using the Pfu polymerase kit (Promega, 
Madison, WI).  The following recipe was used -   
Component    Volume  Final concentration 
Pfu polymerase (3units/ul)  1 ul   3 units 
10X buffer    5 ul   1X 
dNTP (10mM)   2 ul   0.4 mM 
Forward primer (10uM)  1 ul   20 pm 
Reverse primer (10 uM)  1 ul    20 pm 
Template DNA (50 ng/ul)  1 ul   50 ng   
Distilled water    39 ul   -  
 
Appropriate primers, as mentioned in 2.1.3, were used in the reactions, to generate 
PCR fragments that encoded the full-length cDNA.  PCR conditions were as follows: 
Condition    Temperature   Duration 
1. Initial denaturation   94°C    5 minutes 
2. Denaturation   94°C    30 seconds 
3. Annealing *    55- 68°C   1 minute  
4. Extension ^    72°C    1 minute per kb 
5. Final Extension   72°C    10 minutes 
*Approximately 5°C below the Tm of primers 





PCR products were separated using gel electrophoresis (see 2.3.4) and 
visualized using a UV trans-illuminator.  PCR fragments of the right size were excised 
and eluted from the gel (see 2.3.5) before restriction enzyme digestion of the ends and 
ligation with the vector. 
2.3.3 Site-directed mutagenesis 
In order to further understand the role played by the NO-mediated 
phosphorylation event at S-197 of AFX, I constructed dominant negative cell lines 
expressing the protein with a site directed mutation, converting the serine to an 
alanine, which would prevent recognition and phosphorylation of the site.  Forward 
and reverse primers containing the mutated residue were designed, and the high 
fidelity Expand kit (Roche, Basel, Switzerland) was used for the PCR.  The pre-
constructed pcDNA3-AFX construct was used as a template, and the primers were 
used to re-synthesize the entire plasmid, but with the insert containing the mutated 
residue this time. The PCR reaction was set up as follows – 
Component     Volume  Final concentration 
Taq high fidelity polymerase  0.75 ul   3 units 
10X buffer     5 ul   1X  
dNTP (10mM)   2 ul   0.4 mM 
Forward primer (10uM)   1 ul   20 pm 
Reverse primer (10uM)   1 ul   20 pm 
Template DNA (100 ng/ul)   2 ul   200 ng  





The PCR conditions were as follows: 
 
Condition    Temperature  Duration 
1. Initial denaturation   94°C   2 minutes 
2. Denaturation   94°C   15 seconds 
3. Annealing *    55°C    30 seconds 
4. Extension ^    68°C   8 min (for 7 Kb) 
5. Final Extension   68°C   7 minutes 
* Approximately 5°C below the Tm of the AFX S197A primers. 
^ The reaction is repeated up to 14 times, from step 2 to 4. 
 
The PCR products were then digested with DpnI for 2 hours at 37°C.  This 
effectively removed the entire methylated template DNA (the original plasmid was 
from a dam positive, DH5-α transformant, leaving the GATC’s in its sequence 
methylated) leaving behind, only the mutagenised plasmid.  The DNA is purified from 
the salt solution by ethanol precipitation and transformed into nick- repair capable Xl-
1 blue competent cells, by heat- shock.  The plasmids were subsequently sequence 
verified.   
2.3.4 Agarose gel electrophoresis 
1% (w/v) agarose gel was prepared by melting 1 gram agarose in 100 ml of 
TBE buffer (89 mM Tris, 89 mM Boric Acid, 2.5 mM EDTA- pH 8).  0.5 ug/ml 
ethidium bromide was added before allowing the gel to solidify on a gel casting 
mould.  The gel was subsequently immersed in an electrophoresis tank with 1X TBE 
buffer.  6X loading dye (0.1% bromophenol blue, 0.1% xylene cyanol, 40% glycerol) 
was added to the plasmid DNA/ PCR products to a final concentration of 1X, and 
loaded in wells, along with 0.5 ug of a suitable DNA ladder.  Electrophoresis was 





2.3.5 Elution of DNA from agarose gel 
DNA fragments of interest were excised from the agarose gel under UV trans-
illumination, using scalpels.  The QIAquick gel extraction kit was used to elute the 
DNA. Briefly, the excised gel fragment was weighed and a 3X volume of buffer QG 
was added.  The mixture was left at 52°C, with occasional agitation, to dissolve the gel 
thoroughly.  1X volume of isopropanol was then added and the mixture loaded onto 
the mini-columns provided with the kit.  The columns were centrifuged at 12000 rpm 
on a table-top microfuge for 1 minute.  The column (whose resin binds and retains the 
DNA from the mixture) is then washed with buffer PE.  The wash buffer is completely 
removed by centrifugation at high speed.  The DNA is then eluted in a suitable volume 
of buffer TE, by centrifuging at 12000 rpm for 1 minute.   
2.3.6 RE digestion 
The following reaction mixes were set up for restriction enzyme digestion of 
the plasmids – 
Component     Volume  Final concentration 
Plasmid DNA     5 ul   1 ug 
RE  enzyme(s)   0.5 ul   10 units 
10X RE buffer   4 ul   1X 
Distilled water    30.5 ul   - 
 
The mixture was incubated at 37°C for at least 2 hours.  The digestion of the 
plasmids were confirmed by gel electrophoresis and subsequently eluted from the gel, 
for ligation. 
2.3.7 Ligation 
Restriction enzyme digested, sticky-ended plasmid and PCR fragments were 




Component     Volume  Final concentration 
T4 DNA ligase (400 units/ ul) 1 ul   400 
10 X buffer    1 ul   1X 
Vector DNA: insert DNA   upto 500 ng  1:3 ratio 
Distilled water    top up to 10 ul  - 
The reaction mix was incubated at 16°C for 16 hours before transformation 
into competent DH5-α cells. 
In the case of annealing inserts into the pcDNA3.1 vector, the T overhangs 
within the TOPO-conjugated vector were utilized.  The PCR fragments of the insert, 
with A overhangs added by Taq polymerase, was directly ligated onto the linearised 
vector with the T overhangs, and then subsequently transformed. 
2.3.8 Preparation of competent cells 
E.coli (DH5-α or Xl-1 blue) was cultured in 200 ml liquid broth.  Growth was 
monitored to collect cells in the logarithmic phase, at an A600 of 0.3-0.6.  Cells were 
chilled on ice for 15-30 minutes before pelleting by spinning at 4000 rpm for 5 
minutes at 4°C.  The pellet was resuspended in half the volume of cold 100 mM CaCl2 
and incubated on ice for 20 minutes.  The cells were pelleted again and resuspended in 
1/10 th volume of cold 100 mM CaCl2 and incubated on ice for 1 hour.  Sterile 
glycerol was added to a final concentration of 15%, and the cells were aliquoted in 0.5 
ml micro-centrifuge tubes, and stored at -80° C. 
2.3.9 Transformation by heat shock 
The ligation mixture (up to 2 ul, refer to 2.3.7) was carefully mixed with 50 ul 
of competent cells and left on ice, for up to 30 minutes.  The vial was placed in a 42°C 
water bath for 30 seconds and then put on ice, immediately.  After recovery on ice for 




incubated at 37°C for 1 hour.  The cells were then plated on to agar plates, containing 
appropriate concentrations of the selective antibiotics (ampicillin – 100 ug/ ml; 
kanamycin – 50 ug/ ml) and left to incubate at 37°C overnight.  Colonies, if any, were 
picked, grown in liquid broth over night, the plasmid isolated (refer to 2.3.10) and 
checked for transformed cells containing the required construct. 
2.3.10 Isolation of plasmid DNA 
A mini prep kit from Qiagen (Valencia, CA) was used to isolate plasmid DNA 
from transformed cells.  Briefly, logarithmically growing bacterial cell cultures were 
pelleted, and resuspended in ice-cold buffer P1 (250 ul of resuspension buffer for 1 ml 
of cell culture, OD~0.5).  An equal volume of the lysis buffer, P2, was gently mixed 
with the cells.  350 ul of buffer P3 was added to the same, to neutralize the solution.  
The mixture was then spun down at 13000 rpm, for 10 min and the supernatant loaded 
onto the resin spin columns provided with the kit, and centrifuged.  The columns were 
then washed with buffer PE and the DNA eluted from the resin with 50 ul of buffer 
EB.   
2.3.11 Plasmid sequencing for construct verification 
The inserts in all the plasmid constructs made were sequence verified by using 
appropriate primers designed upstream and downstream of the insert, encoded on the 
vector itself, in its multiple cloning region.  A PCR mix was set up as follows – 
Component     Volume  Final concentration 
Template DNA (100 ng/ul)  2 ul   200 ng 
Sequencing primer (10 uM)  2 ul   20 pm 
Big Dye*    8 ul   * 
Distilled water    8 ul   - 
*dNTP mixture along with fluorescent labeled ddNTPs; kindly provided by DNA 






The PCR conditions were as follows - 
Condition    Temperature  Duration 
1. Initial denaturation   94°C   2 minutes 
2. Denaturation   94°C   30 seconds 
3. Annealing     50°C   15 seconds 
4. Extension ^    60°C   4 minutes 
^The reaction is repeated up to 25 times, from step 2 to 4. 
DyeEx columns (Qiagen, Valencia, CA) were used to purify the PCR products, 
following manufacturer’s instructions. 
2.3.12 Sub-cloning of short oligonucleotides 
Cloning of the 3X FOXO cis-element into pGL3 involved the insertion of a 60 
base-pair oligonucleotide, which was achieved by annealing sticky-ended full length 
oligonucleotides, than by conventional ‘PCR with primers followed by restriction 
enzyme digestion of the ends’ technique.  Single stranded full-length oligonucleotides 
were used with relevant restriction enzyme recognition sites at the 5’ ends (in this 
case, NheI and XhoI).  These were annealed by transient heating at 70°C, followed by 
a gradual cooling to room temperature.  T4 polynucleotide kinase was then used to 
phosphorylate the 5’ ends.  The pGL3 vector, cut with the same two restriction 
enzymes, was ligated with the oligonucleotide and transformation performed as in 
2.3.9. 
The small size of the insert also necessitates the use of a special higher 
percentage agarose gel – in this case a 4% Metaphor gel was cast to visualize the insert 







2.3.13 Semi- quantitative RT-PCR 
Various downstream targets of forkheads as well as the mRNA levels of the 
transcription factors themselves were checked using RT-PCR, with primers as listed in 
2.1.3.  In every case, a parallel RT-PCR with β-actin primers was done to normalize 
for the quality and quantity of the template RNA in the reaction mixes.  The one-step 
RT-PCR kit (Promega, Madison, WI) was used to set up RT-PCR reactions; up to 2 ug 
of total RNA (see 2.2.7), isolated from mammalian cells was used as a template.   
The reaction was set up as below – 
Component    Volume  Final concentration 
Enzyme mix*    1 ul   3 units  
10X buffer    5 ul   1X 
dNTP (10mM)   2 ul   0.4 mM 
Forward primer (10uM)  1 ul   20 pm 
Reverse primer (10uM)  1 ul    20 pm 
Total RNA (1 ug/ul)   2 ul   200 ng  
Distilled water    38 ul   -   
* DNA polymerase and reverse transcriptase mix 
 
The RT-PCR conditions were as follows: 
Condition    Temperature  Duration 
1. Reverse transcription  50°C   30 minutes 
2. Initial denaturation   94°C   5 minutes 
3. Denaturation   94°C   30 seconds 
4. Annealing *    55- 68°C  1 minute 
5. Extension ^    72°C   1 minute per kb 
6. Final Extension   72°C   10 minutes 
*Approximately 5°C below the Tm of primers. 






2.4 Protein methodology 
2.4.1 Protein concentration determination by Bradford’s assay 
Bradford’s solution (Bio-Rad, Hercules, CA) was used to quantify whole cell 
and nuclear protein extracts.  1 ml of the Bradford’s solution was mixed with 1-2 ul of 
the protein extract and left to stand at room temperature for 10 minutes before 
absorbance at 595 nm was measured. A standard curve was plotted every time using 
known (serial dilutions from 0 to 2 ug per ml) quantities of BSA and the concentration 
of the protein samples, based on their corresponding absorbance values, was deduced 
from the same.   
2.4.2 SDS-PAGE and Western blot analysis 
SDS-PAGE was carried out as described in standard protocols (Molecular 
Cloning by Maniatis, et al.) using Mini- PROTEAN II electrophoresis system (Bio-
Rad, Hercules, CA) in Tris- glycine buffer (25mM Tris, 250mM glycine, 01.% SDS).  
A 10% polyacrylamide gel was set up and 10 ug each of the protein samples were 
denatured in SDS loading buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 10% Glycerol, 
0.1% bromophenol blue, and 5% β- mercaptoethanol) and heated at 95°C for 5 
minutes before loading.  The resolved proteins were then transferred onto a Hybond C-
plus nitrocellulose membrane (Amersham, UK) using the Bio-Rad wet transfer system 
in transfer buffer (39 mM glycine, 48 mM Tris base, 0.037% SDS, 20% methanol).  
All subsequent immunoblotting was carried out in PBS with 0.1% Tween 20 and 5% 
skimmed milk (henceforth referred to as the ‘blocking buffer’).  The membrane was 
blocked for one hour at room temperature.  This was followed by over-night 
incubation of the membrane in appropriate dilution of the primary antibody in the 
blocking buffer at 4°C.   The membrane was washed extensively (3 times, each lasting 




in blocking buffer containing the appropriate horse radish peroxidase conjugated 
secondary anti-body for 2 hours at room temperature.  The membrane was washed 
extensively as before.  Antigen-antibody complexes were visualized using luminal 
chemilumniscent substrate (LumiGLO reagent, Cell Signalling, Beverly, MA).  
2.4.3 Protein/DNA array analysis 
SH-SY5Y cells were treated with NO donors for the times indicated, and 
nuclear proteins were prepared. The protein/DNA array was performed following 
manufacturer’s instructions (Panomics, Redwood city, CA).  Briefly, the nuclear 
extracts were incubated with biotin-labeled DNA probe mix in binding buffer for 30 
min at 15°C.  Protein/DNA complexes were resolved in a 2% agarose gel and excised. 
DNA probes were recovered from the protein/DNA complexes and hybridized to the 
transignal Protein/DNA array membrane. Hybridization signals were visualized using 
horseradish peroxidase-mediated chemiluminescence. The resulting autoradiograph 
was scanned by densitometry, and the mean values were represented as optical density 
(OD) along with the standard deviation (SD).   
2.4.4 Protein- DNA interaction –electrophoretic mobility shift assay (EMSA) 
Double stranded oligonucleotides were generated by annealing the forward and 
reverse 3X IRS oligonucleotides (as in 2.1.3; encoding 3 successive copies of the 
FOXO cis-element) in annealing buffer by heating at 70°C followed by slow cooling.  
Up to 100 ng of these oligonucleotides were then end-labeled with [γ-P32] ATP and T4 
polynucleotide kinase, by incubation at 37°C for 45 minutes. Mutant 3X 
oligonucleotides with one of the 8 conserved base pairs mutated, was used as a 
negative control in parallel.  Excess unused nucleotides were removed using Biospin 
30 (Bio-Rad, Hercules, CA) columns.  The specific activities of the probes were then 




Component    Volume  Final concentration 
0.5 M Hepes (K+) pH 7.8  25   10 mM 
0.5 M MgCl2    12   5 mM 
25 mM DTT    20   2.5mM 
Glycerol    100   10% 
2.5% NP-40    10   0.05% 
2.5 M KCl    20   50 mM 
 
10 ul of the above mix was gently added to 10 ug of nuclear proteins (see 
2.2.6) and 2 ug of dI-dC was added to the same, as the source of non-specific 
competitor DNA.  An appropriate volume of the probe (up to 100, 000 counts per 
reaction) was added and the mix left to stand at room temperature for 20 minutes, for 
the DNA- protein complexes to form.  In order to prove the specificity of the DNA- 
protein interaction, cold, wild type or mutant oligonucleotides were added to the mix, 
at increasing concentrations, to show the interaction being competed out in the former, 
while in the latter, the DNA-protein complex was unaffected.   
The sample was subsequently mixed gently with 6X DNA loading dye and 
loaded onto a 5% native polyacrylamide gel.  Electrophoresis was carried out in 0.25X 
TBE buffer at a constant current of 25 mA for 3 hours at 4°C.  The gel was then peeled 
off the glass plates and dried and exposed to a BioMax MR (Kodak, Rochester, NY) 
X-ray film to detect the bands. 
2.4.5 Immunoflourescent staining 
Mammalian cells, grown in chamber slides, were fixed with 3.7% para-
formaldehyde solution, for 20 minutes at room temperature.  Cells were then washed 
with PBS and blocked with 1% normal goat serum, diluted in PBS containing 0.1% 
Triton X-100, for 2 hours at room temperature.  The primary antibody (1 in 100 




night.  They were washed 3 times, for 5 minutes each, with PBS containing 0.1% 
Triton X-100, before incubation with appropriate fluorescent labeled secondary 
antibody (1:200-1:500), at room temperature for 2 hours.  All incubations with 
antibodies were carried out in darkened humidified chambers. Cells were again 
washed with PBS containing 0.1% Triton X-100 before being mounted in Vectashield 
(Vector Laboratories Inc., Burlingame, CA).  TOPRO-3 (Molecular Probes, Carlsbad, 
CA) was diluted 1 in 5000 in PBS, and was used to stain the nuclei before mounting.  
Cells were observed and photographed using a Bio-Rad MRC 2000 confocal 
microscope (Zeiss, Germany) connected to a Photometrics Sensys CCD camera. 
 
2.4.6 Localisation studies using GFP tagged proteins 
The sub-cellular localization of GFP-tagged proteins in live cells, after 
appropriate treatments, was observed using an epifluorescence microscope (Zeiss, 
Germany) with an attached Nikon Coolpix CCD camera. 
 
2.4.7 Luciferase reporter assay 
The dual luciferase reporter assay kit (Promega, Madison, WI) was used to 
assay for luciferase activity in transfected cells, according to the manufacturer’s 
instructions.  Cells were transfected with the appropriate pGL3 vector (up to 1 ug per 
dish, on a 6-well plate) and the control Renilla construct (50 ng per dish).  24 hours 
post-transfection, appropriate reagents (NO donors or insulin or tet, as required) were 
added.  At the end of the time courses, cells were washed three times with 2ml PBS.  
The media and the PBS were removed thoroughly as residual NO/ culture media is 




buffer (Promega, Madison, WI) was added to the wells, and the cells were lysed at 
room temperature by shaking gently for 15- 20 minutes.  
The lysate was diluted 10 times by mixing 10 ul the lysate with 90 ul 1X lysis 
buffer.  To 95 ul of the first substrate, 10 ul of the above was added, mixed well and 
the luminescence (emitted by the action of the firefly luciferase, encoded by the pGL3 
construct) noted immediately in a TD-20e luminometer.  95ul of the stop and glo 
substrate was then added, mixed well and the luminometer reading noted again - this 
substrate quenched the activity of the firefly luciferase and at the same time acted as a 
substrate for the Renilla luciferase, encoded by the control Renilla vector.  Assuming 
the stop and glo reading as the equivalent of a 1000 units of luciferase activity, the 
relative luciferase activity of the different constructs of the pGL3 plasmid and the 
treatments were then deduced. 
 
2.5 Cell viability and death assays 
2.5.1 Crystal violet staining and quantitation 
Cells were seeded in 6-well plates for approx. 70% confluency and treated as 
required. The media was aspirated and 0.5% crystal violet in 30% methanol was 
carefully overlaid on the cells and left at room temperature for 10 minutes, to fix and 
stain the cells. The excess stain was completely removed by washing with distilled 
water many times. The plates were then dried. The dye taken up by the cells was 
eluted in 50% methanol, 1% acetic acid solution. Absorbance was measured at 540 nm 
in an immunoabsorbent assay reader. Crystal violet binds proteins and since most dead 
SH-Sy5y cells float away, there is a good correlation between the total viable cell 
number and the absorbance at 540 nm after staining.  Cell death was expressed as a 




2.5.2 Lactate dehydrogenase (LDH) release assay 
Release of LDH from the intracellular compartment into the surrounding 
medium was measured as an indicator of cell death.  Cells were seeded in 96-well 
plates and appropriate treatments were carried out.  The supernatant of the treated and 
un-treated control cells were collected and the cells lysed in an equal volume of lysis 
buffer (Dulbecco’s modified Eagle’s medium with 0.1% Triton X-100), by gentle 
shaking at room temperature for 30 minutes.   
The assay is based on a coupled enzymatic reaction involving the conversion 
of a tetrazolium salt (INT) into a formazan product. The reaction is catalyzed by LDH 
released from cells and diaphorase present in the assay substrate mixture. 
Lactate + NAD(+) --> Pyruvate + NADH 
NADH + INT --> NAD(+) + Formazan 
Final formazan concentrations, which act as an indirect indicator of the LDH 
enzyme activity in the assay mixture, were determined by measuring optical 
absorbance at 492 nm in a 96 well format.  The percentage LDH release is calculated 
by dividing the level of LDH in the medium by the total amount of LDH in the 
medium and the cell lysate together.   
2.5.3  Sytox Hoescht staining 
The membrane permeable DNA dye Hoechst-33342 and the membrane 
impermeable DNA dye Sytox was used to observe cell death morphologically and 
distinguish between apoptosis and necrosis.  50 ul of a 250 uM Sytox stock (in 
DMSO) and 10 ul of a 10mg/ ml Hoechst  stock (both from Molecular Probes, 
Carlsbad, CA), were mixed in 190 ul of DMSO to make a 500X working solution (a 
final concentration of 100 nM- 200 ng/ml Sytox- Hoescht dye mixture was found to be 




treated cells and the plates examined under a fluorescence microscope after incubation 
for 15 minutes at 37°C. 
The nuclei of living cells are stained evenly by membrane permeable Hoechst. 
The cells with bright, condensed chromatin and fragmented nuclei under Hoechst dye 
staining were identified as apoptotic cells. The cells with normal-shaped nuclei and 
stained by Sytox Green were counted as necrotic cells; in my experiments, most of 
these were a result of secondary necrosis, caused by long treatments with NO donors. 
Cells in five random fields under a magnitude of 20X were counted using an 
epifluorescence microscope (Zeiss, Germany) with an attached Nikon Coolpix digital 
camera, to gauge cell death patterns. 
 
2.5.4 Caspase 3 cleavage assay 
The enzymatic activity of caspases was measured by monitoring the cleavage 
of exogenous fluorogenic peptide substrates, yielding 7-amino-4-trifluoromethyl 
coumarin (AFC) as the fluorescent signal.  Cells were seeded in 24- well plates and 
treated for appropriate times with NO donors.  The supernatant was gently removed 
and discarded while the cells were lysed with lysis buffer (1% Triton X-100,115 mM 
NaCl, 1 mM KH2PO4, 4 mM KCl, 1 mM dithiothreitol, 25 mM Hepes, pH 7.4, 1 mM 
benzamidine, 1 mM PMSF, 10 ug/ml phenanthroline, 10 ug/ml aprotinin, 10 ug/ml 
leupeptin and 10 ug/ml pepstatin) on ice for 10 minutes.  The lysates (20 ul from a 
total of 250 ul) were diluted to a final volume of 100 ul with substrate buffer (60 mM 
fluorogenic substrate DEVD-afc in 50mM HEPES pH 7.4, 1% sucrose, 0.1% CHAPS, 
10mM DTT) for detection of caspase-3-like activity. The generation of free AFC at 
37°C was kinetically determined over a period of 30 minutes by fluorescence 




reader (Tecan, Crailsheim, Germany). The specific activities (pmol afc/min*mg 
protein) were calculated using the protein concentrations of lysates as determined by 












CHAPTER 3  -  RESULTS 
3.1 NO mediated regulation of FOXOs 
3.1.1 Cis-element array shows NO increases binding of FKHR consensus cis- 
elements 
In an attempt to obtain an overview of all the different transcriptional changes 
effected by NO in cells, we chose to treat SH-Sy5y cells with cytotoxic concentrations 
of SNP for 2 to 12 hours, and isolated the nuclear extract.  A TranSignal protein/DNA 
array (Panomics, Redwood city, CA) spotted with 150 different consensus 
transcription factor-binding sequences, with each recognition sequence corresponding 
to a specific transcription factor, was used. Biotin-labeled oligonucleotides 
(TranSignal Probe Mix) were pre-incubated with the nuclear extracts to allow the 
formation of protein/DNA (or TF/DNA) complexes.  The protein/DNA complexes 
were then separated from the free probes, and the probes in the complexes were then 
subsequently extracted and hybridized to the TranSignal Array. Signals were detected 
using chemiluminescence imaging.   
The array picked up changes in the levels of a few of the transcription factors 
binding to their respective cis-elements upon NO treatment - changes that were 
subsequently confirmed by conventional EMSA (Dhakshinamoorthy et al., 
unpublished). 
Various known and novel changes in DNA-binding affinity were observed, 
including AP1, AP2, Brn3, Cre, EGR, PPAR, E2F and FKHR.  Beginning from 4 
hours after treatment with SNP, there was a significant increase in the binding to both 
the mouse and human FKHR consensus elements as shown in Fig. 4. I decided to 
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Figure. 4 FOXO cis-elements on TranSignal protein-DNA array. Increased 
binding affinity of NO-treated SH-Sy5y nuclear proteins to mouse and human 




3.1.2 Increased binding of FKHR consensus cis-elements confirmed by EMSA 
The human IRS promoter which responds to FOXO transcriptional control via 
the conserved FKHR elements in its promoter, was chosen as the basis for designing 
oligonucleotides to perform an EMSA (Guo et al., 1999).  A 35 base-pair sequence 
containing the core CAACAAAA FKHR recognition element (Fkhr RE) was end-
labeled with [γ-P32] ATP.  100,000 cpm of the labeled FKHR RE was then incubated 
with 10 ug of NO-treated SH-Sy5y nuclear extracts and analyzed in a 5% native 
polyacrylamide gel.  The shifted FKHR-nuclear protein complex is arrowed in Fig. 
5A. In a similar experiment, in order to prove the specificity of the interaction between 
the nuclear proteins to the FKHR RE, competition assays were set up using cold 
FKHR oligonucleotides or oligonucleotides with the key recognition site mutated (Fig. 
5B).  The former increasingly competed out the appearance of the labeled 
oligonucleotide-protein complex with increasing concentrations, whereas the mutant 
oligonucleotide showed no such competing effect; the same is re-emphasised in the 
graph in Fig. 5C, which shows a quantitation of the shifts observed – nuclear extracts 
of cells treated with Deta-NO for 4 hours were used in the above experiment.  Panel D 
on Fig. 5 shows the sequence of the FKHR-specific oligonucleotide used.  The EMSA 
clearly confirmed the increase in FOXO DNA binding seen in the array after NO 
treatment of SH-Sy5y cells – the inherent differences in the nature of the two NO 
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Figure 5. EMSA with Fkhr RE (A) NO enhances the binding of nuclear proteins 
to the Fkhr cis-element.  EMSA with labelled FKHR RE - panel on the left shows 
interaction with nuclear proteins after 1.5 mM Deta-NO treatment of SH-Sy5y 
cells while the panel on the right shows the same, but with 2 mM SNP-treated 
cells. (B) Competition assay.  Unlabelled Fkhr and mutant Fkhr cis-elements were 
incubated with the labeled oligonucleotides in increasing concentration, with 4 
hour Deta-NO treated nuclear extracts, to prove the specificity of the observed 
shift. (C) Quantitation of the above proving the specificity of the observed shift.  


























3.1.3 NO-mediated down-regulation of FOXO transcriptional activity 
To investigate whether the increase in DNA binding also affected the 
transcriptional activity of the FOXO proteins, I decided to look at the functionality of 
the FKHR recognition elements in mediating transcription after NO treatment.  The 
pGL3 luciferase reporter system was used for this purpose.   
The over-expression of AFX in an increasing concentration, resulted in a 
significant up-regulation of the pGL3-3X IRS-dependent luciferase gene expression 
(pGL3-3X IRS contains 3 successive copies of the FKHR RE from the FOXO 
responsive IRS gene promoter) (Fig 6A).  Treatment with 2mM SNP, however, 
suppressed the basal activity by up to 30%, beginning around 8 hours post-NO 
treatment (Fig. 6B). Parallel experiments with another NO donor, Deta-NO, also show 
a 30% reduction from basal activity, starting 8 hours post treatment (Fig. 6C).  But the 
difference in the mechanism and concentration of NO (and other by-products, 
especially peroxynitrate, a by-product of the breakdown of SNP) released by the 2 
donors, brings up subtle differences in the early transcriptional activation kinetics.  It 
is worth mentioning here that, with the similarity in the transcriptional down-
regulation and DNA binding profile, seen with both Deta-NO and SNP, at 8 and 12 
hours post- treatment, and the induction of S197 phosphorylation around 8 hours (see 
Fig. 7B), will mean a similar effect of the 2 donors, on FOXO regulation and activity- 
hence, at least in the responses starting 8 hours from NO treatment.  Hence, both the 
donors were treated without any prejudice in the study.  Attempts were also made to 
duplicate most experiments with both donors and through out the study, no major 
differences were observed in any of the NO mediated effects on FOXO.  The insulin – 
PI3 Kinase – PKB pathway, where insulin is known to cause phosphorylation of 




Treatment of serum-starved NIH-3T3 cells with 1ug/ml insulin/ serum caused a fall in 
luciferase activity as previously reported (Kops et al., 1999) (Fig. 6D).  
In order to rule out any generic fall in luciferase activity/ FOXO transactivation 
with time, the above experiments were performed in parallel in medium without NO 
donors.  Luciferase assays at appropriate time points did not show any change in the 
levels of enzyme activity without NO (data not shown).   
 
3.1.4 AFX mRNA and protein status in NO-treated cells 
In order to ascertain if the NO-induced changes in the DNA-binding and 
transcriptional activation were due to expression level changes of the FOXO 
transcription factors, I checked the mRNA and protein levels of the FOXO proteins by 
RT-PCR and western blotting, respectively.  SH-Sy5y cells were treated for 2, 4, 8 and 
12 hours with 2 mM SNP and the cells were harvested for subsequent total RNA and 
protein extraction.  RT-PCR analysis was carried out with suitable primers.  
Representative results for AFX, along with β-actin controls, are shown in Fig. 7A.  
Nuclear extracts were made and the expression levels of the proteins were determined 
using suitable antibodies by western blot analysis (left panels on Fig.7B, C).  No 













































































Figure. 6  Induction of 3X IRS-mediated luciferase activity by co-expression of 
AFX and its down-regulation by insulin and NO treatment.  (A) SH-Sy5y cells 
were transfected with 1ug of the pGL3-3XIRS plasmid and the AFX expression 
plasmid (in increasing concentrations) as shown; and the cells analyzed for 
luciferase activity. (B) SH-Sy5y cells were transfected with 1 ug of pGL3-3XIRS 
and 24 hours post transfection, 2 mM SNP containing media was added to the 
cells for 2, 4, 8 and 12 hours before harvesting and analysis for luciferase 
activity. (C) As in B, but 1.5 mM Deta-NO was used as NO donor. (D) NIH-3T3 
cells were transfected with 1 ug of the pGL3-3XIRS plasmid. 24 hours post 
transfection, the cells were grown in serum-starved conditions before induction 
with serum and serum containing 1 ug/ml insulin for 30 minutes, before 
harvesting and analysis for luciferase activity. 0.1 ug of plasmid pRL-Tk, 
encoding Renilla luciferase, was used as a control for normalizing the efficiency 
of transfection in every case. The results obtained are representative of multiple 
independent experiments.


























3.1.5 NO induces AFX phosphorylation at Ser 197  
Since phosphorylation is a major means of FOXO transcriptional activity 
regulation, I followed up the protein analysis with antibodies available against specific 
phospho-FOXO proteins.  Various commercial antibodies against the known serine 
and threonine phosphorylation sites on the FOXOs (see Fig. 1) were used.  The AFX 
phospho-Ser197 antibody was found to detect increasing amounts of phosphorylated 
proteins in the nuclear extracts of SH-Sy5y cells exposed to NO donors for 8 hours or 
more (right panel on Fig. 7B).  Parallel positive controls were set up by exploiting the 
known phosphorylation of FOXO proteins in NIH-3T3 cells upon insulin treatment.  
Cells were serum starved for 24 hours and then recovered in medium containing serum 
and 1ug/ml insulin.  Insulin is known to cause phosphorylation of AFX at Ser197, 
among other sites, and the western blot clearly showed the known insulin-mediated 
phosphorylation of AFX at Ser197 (right panel on Fig. 7B).   
As seen in Fig. 1, Ser 256 is the equivalent analogous serine, comparable to the 
serine at 197 in AFX, implicated in the insulin- PI3Kinase- PKB pathway of 
phosphorylation of FOXOs.   Interestingly, NO-mediated phosphorylation of FKHR 
was observed with a phospho-Ser 256 antibody after 8 hours of treatment with NO 
donors (right panel on Fig. 7C).  The high degree of homology between these two 
proteins along with the published literature evidence that usually club them together 
on most occasions in growth factor and stress mediated pathways, further strengthens 
the possibility of NO modulating FOXO functions and thereby probably affecting the 
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Figure 7.  AFX mRNA and protein levels in cells after NO treatment.  (A)  SH-
Sy5y cells were treated with 2 mM SNP for various times and the RNA isolated 
was used for RT-PCR analysis of the AFX mRNA. β-actin is shown as a 
control.on the right panel.  (B) 2 mM SNP-treated SH-Sy5y nuclear extracts (10 
ug each) were analysed for AFX protein expression by Western blotting.  Panel 
on the right shows the same nuclear extracts, but probed with antibody against 
AFX phospho-Ser197.  Serum starved cells (denoted as InsC on the panel) and 
serum-starved cells recovered with serum and 1 ug/ ml insulin for 30 minutes 
(denoted as InsT on the panel) served as a control for the observed 
phosphorylation. (C) Panel on the left shows 2 mM SNP-treated SH-Sy5y 
nuclear extracts probed with antibody against FKHR; panel on the right shows 
the same, but probed with antibody against FKHR phospho-Ser256.
S256 pFKHR
0        2       4      8      12 (h)      
2mM SNP     
C       2        4        8      12     (h)
2mM SNP     
FKHR
βactin
C         2       4         8       12     (h)




3.1.6 NO-mediated phosphorylation at Ser197 does not cause nuclear export of 
AFX  
Insulin-dependent PI-3 Kinase- and PKB-mediated phosphorylation of Ser-197 
is known to cause the translocation of AFX from the nucleus into the cytosol.  I 
wanted to check if NO-mediated phosphorylation at this site also prompted the nuclear 
export of the protein.  Fluorescent antibodies were used to stain NO-treated and 
untreated SH-Sy5y cells to track any translocation of the protein.  
Immunofluorescence revealed that under normal conditions, AFX (red) was localized 
in the nucleus (Fig. 8A). NO did not cause any translocation of the protein from the 
nucleus (nucleus stained blue with TO-PRO 3) under conditions in which Ser-197 of 
AFX is phosphorylated. Insulin treatment for 30 minutes, on the other hand, caused 
sequestration of the protein in the cytosol (Fig. 8B).   
Live tracking of the protein was also attempted such that any transient 
translocation of the protein outside the discrete time points used during immuno 
fluorescense is not missed.  For this purpose, a GFP-tagged AFX construct was made, 
and transiently transfected SH-Sy5y cells were constantly monitored for the 
localization of the protein after NO treatment; but AFX appeared to remain 

















Figure 8.  Immunofluourescense to check localisation status.  (A)  SH-Sy5y cells 
were grown in chamber slides and treated for 8 hours with 2 mM SNP, as shown.  
After treatment, the cells were fixed, washed and stained with AFX antibody, 
appropriate flourescent secondary antibody and TO-PRO 3, as in 2.4.4.  AFX 
staining is shown in red, TOPRO3 staining is shown in blue.  The purple merge 
panel shows the localization of AFX in the nucleus.  (B)  NIH-3T3 cells show 
AFX translocation after 30 minutes of treatment of serum starved cells with 1 




3.1.7 S197A mutants 
To further understand the significance of the NO-induced phosphorylation at 
serine 197 of AFX, the serine was modified to an alanine, such that the site can no 
longer be phosphorylated.  The mutant pcDNA3 construct is denoted as AFX S197A.   
Luciferase assays were set up in order to investigate the effect of the mutation 
on the transcriptional activity of AFX.  Transient transfection of pGL3-3XIRS and the 
control Renilla vector were done. The pcDNA3 constructs with the full length native 
AFX or the mutant AFX were co-transfected into the cells.  Treatment with NO donors 
24 hours post transfection was followed by analysis of luciferase activity.  As seen in 
Fig. 9A, the 30% fall in luciferase activity seen with AFX co-expression was not 
observed in the case of the AFX S197A co-expression, post-NO treatment. This 
implicates the phosphorylation at S197 as a probable mediator of the decrease in 
FOXO transcriptional activity observed upon NO treatment. But the fall in AFX 
transactivation upon introduction of the S197A mutant in untreated cells raises the 
question of the effect of the expression of the dominant-negative construct per se in 
mediating the transcriptional effect of AFX. It is to be noted that the FKHR 
recognition sequence used in these experiments is generic to the FOXO family and 
some interference of the other FOXO proteins could be expected.  The significance of 
the phosphorylation at S197 is still inconclusive – further experiments with whole 
promoters of appropriate down stream targets and/ or promoter fragments that respond 














































Figure 9.  Luciferase assays with S197A AFX and tet-inducible AFX. (A)  
pGL3-3X IRS was co-transfected into SH-Sy5y cells with 0.5 ug of pcDNA3 
expression vectors with native AFX or S197A AFX inserts.  24 hours post 
transfection, the cells were treated with 1.5 mM Deta-NO for 8 hours. Luciferase 
assay results are as shown. Cells not treated with NO show similar luciferase 
values 24 and 32 hours post transfection. (B) Stable tet-inducible AFX cells were 
transfected with pGL3-3X IRS.  Bar (i) shows luciferase activity of the cells 40 
hours post transfection.  Bar (ii) shows luciferase activity after 12 hours of 1 
ug/ml tet induction, 24 hours post transfection. Bar (iii) represents the fall in 
activity when the tet-induced cells are further treated with NO for 8 hours. Bar 
(iv) represents the luciferase activity of the same condition, but without NO 
donors in the medium – it shows enzyme activity levels similar to that seen after 
only tet induction (bar ii). pRL-Tk, encoding Renilla luciferase, was used as a 
control for normalizing the efficiency of transfection in every case. The results 




3.1.8 AFX over-expression studies 
In order to further understand the role of AFX-mediated transcriptional 
changes in the SH-Sy5y cell response to cytotoxic concentrations of NO, AFX over-
expressing cell lines were developed.  Since FOXO proteins are known to be death 
mediators, the tet-inducible pcDNA4 system was chosen as the preferred vector 
construct for over-expression of the protein. 
AFX cDNA was cloned into the pcDNA4 vector and the construct transfected 
into tet repressor-expressing Tet-12 cells, in order to generate SH-Sy5y cells 
producing tet-inducible AFX.  Various parameters (concentration, time of induction, 
etc.) of tet induction were tested.  An 8 hour induction protocol with 1 ug/ml tet was 
found to be suitable to induce AFX in SH-Sy5y cells (Fig. 10A).    
The 30% fall in FOXO transcriptional activity upon NO treatment was 
reconfirmed in stable cells expressing tet-inducible AFX.  The p4-AFX cells were 
seeded in 6 well plates and the pGL3-3X IRS constructs along with the control Renilla 
construct were transiently transfected.  Tet induction increased the luciferase activity 
by at least 6-fold. 8 hours of treatment with NO donors reduced this activity by 30%.  
Parallel treatment with medium without NO donors was without effect, confirming the 
NO-specific effect on the transcriptional capacity of FOXO consensus elements (Fig. 
9B).  However, the NO mediated decrease in the transcriptional activity of AFX 
should be seen in perspective, along with the massive apoptosis triggered by AFX 
over-expression in SH-Sy5y cells (see below; Fig. 10 B and 10C) – a decreasing 
pattern in endogenous AFX transcriptional activity is seen to begin from 8 hours post-
NO treatment (Fig. 6B and 6C) and we decided not to look beyond the early 8 hour 





AFX is known to be an important modulator of cell death/ survival signals in 
cells.  The fact that NO, another molecule that can determine cell viability, modulates 
FOXO function, immediately suggests that NO-modulated AFX might regulate 
apoptosis in mammalian cells.  The p4-AFX cell lines were used to examine the effect 
of over-expression of AFX on cell death in SH-Sy5y cells.  As seen in Fig. 10B, mere 
tet induction was enough to induce apoptosis.  Further addition of NO donors did not 
further increase cell death.  The above result was confirmed by using both NO donors 
and measuring cell death using various methods, including Sytox-Hoechst staining and 
LDH release assays (Fig. 10B, C). 
The cell death sensitization might be modulated towards either pro- or anti- 
apoptosis by the S197 phosphorylation.  Parallel experiments with S197A and S197D 
stable cell lines will help further understand the role of the S197 phosphorylation in 
modifying cell death after NO treatment in neuroblastomas.  These will also need to be 
correlated with the identification of appropriate direct or indirect transcriptional targets 
of AFX that transmit the signals further downstream.  The transcriptional profiles of 
these protein(s) and promoter analyses using EMSA and functional reporter assays, 
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Figure 10.  Tet-induced over-expression of AFX in SH-Sy5y cells sensitizes cells 
to apoptosis. (A) Western blot analysis of SH-Sy5y cells that stably over-express 
AFX after 8 hours of induction with 1 ug/ml tet; bottom panel shows 
corresponding Western blot for the β-actin control.  (B) LDH release.  SH-Sy5y, 
vector control and AFX stable cells were induced with 1 ug/ml tet for 8 hours; 
cells were then either recovered in normal media (“untreated”) or treated with 1.5 
mM Deta-NO, for 12 and 24 hours.  The cell supernatants and the lysates were 
then subjected to the LDH assay and the percentage cell death calculated.  (C) 
Sytox- Hoechst staining.  Cells were treated as in (B) and stained with Sytox-





3.1.9   NO regulation of known FOXO target genes 
FOXO is known to play a part in the transcriptional regulation of a number of 
genes.  Most of these are involved in the regulation of cell death, cell cycle control and 
cyto-protection.  NO-mediated changes in the mRNA expression profiles of genes 
known to be downstream of forkheads should predict which NO-mediated changes in 
protein levels might occur as a result. We can subsequently correlate these changes 
with any change in sensitivity to cell death after NO treatment, and after AFX over-
expression. With this purpose in mind, semi- quantitative RT-PCRs were set up. 
Gadd45α, p130, Bcl-6, cyclin D1, catalase, MnSOD and BimEL were chosen, 
being known FOXO targets potentially involved in apoptosis initiation or 
cytoprotection.  SH-Sy5y cells were treated with NO donors and total RNA was 
extracted from cells.  Semi-quantitative RT-PCR was set up for each of the different 
genes, and expression patterns after 2, 4, 8 and 12 hours of NO treatment were noted 
(Fig. 11). 
An increase in Gadd45α mRNA after NO treatment was immediately obvious.  
p130, Bcl-6, cyclin D1, catalase showed a gradual decrease in mRNA transcript levels, 
post-NO treatment.  p130 is particularly interesting as its mRNA abruptly decreases 
after 8 hours of NO treatment.  This incidentally coincided with the time frame of the 
increased DNA-binding and the decreased luciferase activity of the FOXO cis-element 
and the AFX phosphorylation observed in my study (Fig 5A, 6B and 7B, respectively). 
Further involvement of these genes in mediating the pro-death effects of AFX 
after NO treatment will require an analysis of their promoter regions.  EMSA showing 
AFX and phospho-AFX binding to the promoters, and NO modulating this binding, 
along with reporter assays that show the functional significance of the NO effect on 




this novel transcriptional effect of NO.  The tet-inducible AFX system will also help 
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Figure 11.  RT-PCR analysis of genes known to be downstream of FOXO 
factors.  SH-Sy5y cells were treated with 2 mM SNP; cells were subsequently 
lysed. and the total RNA extracted was used for semi-quantitative RT-PCR 
analysis of Gadd45-α, p130, Bcl-6, cyclin D1, catalase, MnSOD and Bim El. 




3.1.10   Discussion 
Various transcription factors have been identified to be modulated by NO in 
various cell types including neurons.  Most factors directly respond to the change in 
the redox status of the cell, or are oxidized or nitrosylated by NO or RNIs, while a few 
discrete signaling pathways are also known to be activated upstream of transcription 
factors, resulting in kinase cascades and subsequent effects on transcription factors and 
gene targets further downstream (see section 1.3).   
The Panomics protein/ DNA array showed a collection of cis-elements that 
respond to NO treatment of SH-Sy5y cells. These implicated some known 
transcriptional factors such as AP-1, AP-2, CREB, Sp-1, EGR, STAT and ARE along 
with some novel factors or elements including Brn3, PPAR, CRE, E2F and FKHR.  
Various other factors including SRE, CEBP, ERE, Ets, ISRE, IRF, NF-1, HNF, GRE 
and GATA were found to be unaffected (Dhakshinamoorthy et al., unpublished).     
 In particular, FOXOs, known to play important roles in initiating apoptosis, 
regulating cell cycle progression and the initiation of quiescence in various cell types, 
have been identified as novel targets of NO in neuroblastoma cells in my study.   
 NO-mediated increase in DNA-binding was accompanied by a decrease in its 
transcriptional activation capacity. This indicates a scenario where the particular 
FOXO transcription factor acts as a repressor.  FOXO proteins do have a precedence 
for acting as repressors of gene transcription – downregulation of cyclin D1 and 
survivin promoters has been observed (O'Connor et al., 2000; Tran et al., 2003).  In 
this case, limited NO-mediated down-regulation of cyclin D1 mRNA levels is 
observed – the phenomenon subscribes to the pattern of increased DNA-binding and 




studies; but further analysis of the NO and AFX effects on the cyclin D1 promoter 
needs to be done before any conclusive results can be drawn.   
 Further examination of FOXO expression levels showed there was no NO-
mediated change in the mRNA or protein levels of the proteins.  However, 8 hours of 
NO treatment produced a sharp increase in Ser197 phosphorylation of AFX, which 
coincided with increased cis-element binding and a decrease in reporter activity. AFX 
phosphorylation at Ser197 has been shown to be the primer for the subsequent 
phosphorylation of T32 and S262 in the insulin-PI3Kinase-PKB pathway; though 
phosphorylation at this site has been proved to be vital for Akt-mediated nuclear 
export of AFX, with or without the phosphorylation at the other two sites, in some 
instances (Zhang et al., 2002).   
 Interestingly, NO does not appear to cause any change in the localization of 
this protein in my study.  The absence of commercial phospho-specific antibodies for 
the other sites precluded analysis of their phosphorylation status. But the continued 
retention of phospho-AFX only further supports my observations of the increased 
DNA-binding affinity and the decreased reporter activity of the FOXO elements. In 
any event, nuclear exclusion will eliminate any possibility of AFX-mediated effects on 
promoter elements. It is interesting to note that the recently identified FOXO 
homologue, FOXO6, lacks the 14-3-3 binding motif, and is completely nuclear; but its 
transcriptional activity is still effectively regulated by growth factors to the same 
extent as the other FOXOs (Van Der Heide et al., 2004).  FOXO translocation, hence, 

















Figure. 17.  Schematic representation of NO regulation of AFX. 
 
 The S197 site is also part of the DNA-binding domain of the AFX protein.  
Earlier reports have shown that phosphorylation at this site can affect the affinity of 
the protein to bind negatively-charged DNA. The decreased functionality of the FOXO 
cis-element, seen with luciferase assays (Fig. 6B and 6C), appears to suggest that NO 
could indeed negatively regulate FOXO activity by this phosphorylation event, though 
the increase in DNA-binding I observed (Fig. 5A) appears to be contradictory.  The 
identification of particular downstream targets that respond to NO-mediated AFX 
transcriptional regulation and further analysis of its promoter for AFX binding motifs, 
along with DNA binding studies and reporter assays of the whole promoter (native and 
with the FOXO site mutated), are crucial before we can conclusively understand the 
implication of the S197 phosphorylation. 
  Since all the transcriptional changes observed were the responses to cytotoxic 
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involved in regulating the cell cycle and apoptosis, AFX over-expressing stable cell 
lines were developed to further examine the role played by AFX in the neuroblastoma 
response to NO.  Tet-inducible over-expression of the protein greatly increased the 
susceptibility of SH-Sy5y cells to apoptosis, in the absence of NO.  In fact, the 
susceptibility was so massively enhanced that no additional sensitivity to NO could 
possibly be obtained when compared to SH-Sy5y cells with endogenous AFX (see Fig. 
10B and 10C).   
 NO appears to affect the transcriptional profile of a subset of genes that can 
influence the survival of the cell – the increase in the mRNA levels of Gadd45-α and 
the decrease in the level of catalase, cyclin D1 and MnSOD may tilt the cells towards 
cell death (via growth arrest, loss of free radicle scavenging potential, etc.) but there 
could be a counterbalancing force via the decrease in Bcl-6, p130 and BimEL mRNA 
transcripts.  The sum effect of these (and other) gene expression profiles will 
ultimately decide the fate of the cell.  But only a closer examination of the effect of 
NO on the respective promoters of these genes will shed light on the particular role of 
AFX in NO-induced apoptosis in neuroblastomas (it should be noted that all the 
above-mentioned genes are known to have FOXO cis- elements in their promoters, 
and have been shown to be under FOXO regulation in other signaling pathways or 
during growth factor deprivation). 
The development of site directed mutants of the Ser197 site will also be helpful 
in understanding the role of AFX.  Conversion of serine to alanine in AFX-expression 
constructs inhibited the 30% fall in reporter activity seen with the native AFX 
constructs following NO-treatment.  Similar studies with serine to aspartate mutants, 
which will mimic phosphorylation at the site, should complement the above 




phosphorylated, post- NO treatment, the massive over-expression of protein in the 
system, prevents us from drawing any conclusions from the observation.  Cell death 
assays with stable over-expression of the above mentioned site directed mutant 
constructs will give a clearer picture of any definitive role played by AFX, and 
phospho- AFX in particular, in NO-mediated cell death in neuroblastomas. 
 A handful of kinases have been implicated in the phosphorylation of FOXO 
proteins in cells (see Fig. 1). But most of these are part of signaling cascades 
responding to insulin or other growth factor deprivation.  The S197 site in AFX that is 
observed to undergo NO-mediated phosphorylation is part of a PKB-recognition motif 
and is known to be phosphorylated by PKB and SGK.  However, the question of 
which kinases are involved in NO-mediated phosphorylation of AFX S197 in 
neuroblastoma cells requires additional experiments involving the use of specific 
kinase inhibitors and S197A knock in.   
 
3.2   NO mediated regulation of CHOP 
3.2.1 NO-mediated CHOP induction in SH-Sy5y cells 
The role of CHOP (GADD153) in NO-mediated cell death in cells with wild 
type p53 is not well documented.  Following up on the Gotoh et al. study in RAW 
264.7 macrophages in which CHOP was shown to be induced downstream of bacterial 
lipopolysacharides and interferon- γ treatment (mediated via NO) (Gotoh et al., 2002), 
I decided to examine the role of CHOP in mediating cell death in SH-Sy5y cells after 
NO treatment. 
To investigate a role for CHOP in NO-mediated cell death, the mRNA and 
protein levels of CHOP were analyzed following NO treatment.  I treated SH-Sy5y 




lysates. The former was used as template for semi-quantitative RT-PCR.  NO 
treatment was shown to steadily increase the CHOP mRNA transcript levels in SH-
Sy5y cells (Fig. 12A).  Western blotting with CHOP antibody using cell lysates from 
NO-treated cells showed that the increase in mRNA was reflected in a comparable 
NO-mediated increase in CHOP protein (Fig. 12B). It is interesting to note that the 
durations after NO treatment at which I observed increases in CHOP mRNA and 
protein correlate with the onset of cell death (Feng et al., 2002) as well as the onset of 
AFX phosphorylation (Fig. 7B).  
3.2.2  Inducible CHOP cell lines 
Since the cellular response of neuroblastoma cells to NO involves an increase 
in CHOP, cell lines over-expressing CHOP in parallel with CHOP knock downs will 
be essential to further investigate the possible role played by CHOP in NO-mediated 
cell death in neuroblastoma cells. As part of a research collaboration, I obtained the 
tet-inducible CHOP sense- and anti-sense-expressing stable SH-Sy5y cell lines 
developed by C. Redfern, University of Newcastle, UK (Corazzari et al., 2003). 
The CHOP expression levels were checked in these cell lines after tet 
induction.  To begin with, it was observed that CHOP levels in the vector control cells 
were elevated when compared to the wild type SH-Sy5y cells. But among themselves, 
the vector control, sense and anti-sense CHO stable cells showed similar levels of 
CHOP expression (data not shown).  The elevated levels could be explained by 
differences that could be inherent in the parent SH-Sy5y line used in the collaborators’ 
lab, which were used to generate the stable cells.  It is also possible that the process of 
selection with the two antibiotics could have increased general stress levels in the 
cells, which might be reflected as elevated CHOP protein levels.  Nevertheless, 24 
hours of induction with 1 ug/ml tet showed at least a three-fold increase in CHOP  
82
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Figure 13. Tet-inducible stable cell lines expressing sense- and anti-sense 
CHOP.  (A) Western blot analysis of SH-Sy5y, vector control (V), sense-CHOP 
(S) and anti-sense CHOP (AS) cells after 1 ug/ml tet induction for 24 hours.  The 
panel on the right shows tet-induced cells further treated with 1.5 mM Deta NO 
for 12 hours prior to Western blot analysis of CHOP expression. (B) 
Quantitation of the above blot, showing relative levels of CHOP expression as 
fold changes.
Figure 12. NO induces CHOP mRNA and protein expression. SH-Sy5y cells 
were treated with 2 mM SNP and total RNA and whole cell extracts prepared.  
(A) RT-PCR showing increasing levels of CHOP mRNA with NO treatment.  (B) 
Western blot analysis showing the increase in CHOP protein.





























protein yield in the sense-CHOP stable cells. The anti-sense stable cell line, on the 
other hand, did not show an appreciable decrease in CHOP upon tet induction (Fig. 
13A, left panel). Deta-NO treatment in addition to tet induction resulted in a further 2-
fold induction of CHOP expression with the sense CHOP construct, whereas only a 
slight reduction in CHOP expression occurred with the anti-sense CHOP stable cell 
lines (panel on the right in Fig. 13A; also quantified in Fig. 13B).   
 
3.2.3 Cell death 
The tet-inducible CHOP sense and anti-sense cell lines were then used to study 
the effect of CHOP on NO-mediated cell death.  The cells were seeded in 24 well 
plates, along with vector control and wild-type SH-Sy5y cells, then tet-induced 
followed by NO treatment.  Various means of measuring cell death including crystal 
violet uptake, LDH release assays and Sytox-Hoechst staining/ counting were 
performed (Fig. 14).   
Over-expression of CHOP sensitized SH-Sy5y cells to NO-mediated cell death 
by a modest 7%, whereas cells with lower levels of CHOP due to the induction of the 
anti-sense construct showed up to 15% protection from cell death, when compared to 


























































Figure 14. CHOP over-expression sensitizes SH-Sy5y cells to NO-mediated cell 
death; CHOP knock down protects. (A) Sytox-Hoechst staining of stable cell lines 
along with the vector control and wild type SH-Sy5y cells – tet induction for 24 
hours was followed by treatment with 2 mM SNP for 12 and 16 hours before 
staining for visualization of cell death.  (B)  Multiple fields were chosen and live 
and apoptotic cells counted after Sytox-Hoechst staining, to deduce percentage 
death. (C) Crystal violet staining was carried out under similar conditions and the 
percentage of cell death calculated as in 2.5.1.





NO-induced apoptosis is generally considered to be mediated by DNA damage 
or mitochondrial damage (see 1.2.5); however, the cascade leading to cell death has 
not been fully clarified, and variations in the response to death stimuli definitely exist, 
dependent on the cell type and nature of the death signal.  The ease with which NO 
can affect the integrity of proteins in the cell through the various oxidative, nitrosative/ 
nitrosylative reactions and its effect on the redox status of the cell, would suggest the 
ER stress pathway being a likely candidate for mediation of apoptosis. 
Experiments with RAW264.7 macrophages showed NO-dependent up-
regulation of Bip/Grp 78 and the activation of ATF6 as well as other markers of ER 
stress.  p50, the cleaved product of ATF6 post-ER stress, has been shown to induce the 
expression of CHOP through the ERSE element in its promoter (Gotoh et al., 2002).  
NO-dependent, ER stress-mediated CHOP up-regulation has also been shown in B cell 
islets.  The latter are known to have a particularly weak p53 response to NO.  Though 
the involvement of CHOP and ER stress in NO-mediated apoptosis seems likely, the 
mechanism of action of CHOP remains unclear. 
NO-mediated CHOP up-regulation in neuroblastoma cells was shown for the 
first time in my study (as in Fig. 12).  The mRNA and protein up-regulation was 
marked only after 8 hours of treatment with cytotoxic concentrations of NO donors, 
which correlates with the onset of NO-induced apoptosis(Feng et al., 2002), 
anticipating a role in cell death. 
In order to further analyze the role of CHOP in neuroblastoma cell death, 
stable cell lines with tet-inducible CHOP over-expression and tet-inducible anti-sense 
CHOP expression were employed.  The amount of cell death with NO following 




whereas protection was slightly but significantly noticeable with the antisense 
construct. One possible explanation for the relatively minor effects of sense or anti-
sense CHOP on NO-induced apoptosis might be that NO-induced endogenous CHOP 
mRNA is already saturating and maximizes cell death (to its best possible extent); and 
consequently, tet-induced exogenous CHOP cannot mediate much additional killing. 
On the other hand, the anti-sense CHOP only marginally reduces CHOP mRNA, and 
so the NO-induced endogenous sense CHOP mRNA would presumably hybridize to 
what little anti-sense is expressed, and counteract its effect. Another possible 
disadvantage could be the inherent ‘leakiness’ of the tet induced expression systems.  
It is established that there are several NO-induced cell death pathways in 
neuroblastoma cells (Brune et al., 1999), and over-expression of CHOP alone would 
not in any event be expected to overwhelmingly affect the outcome of NO treatment.  
Thus, the results also imply the relative importance of the ER stress pathway in 
mediating apoptosis in neuroblastoma cells, acknowledging the existence of robustly 
functioning p53 and the MPT pathways and their obvious effects on NO-mediated cell 
death.  This is further confirmed by the study in beta cell islets where the p53 pathway 
is known to be rather weak – this accentuated its susceptibility and up to 50% 
increased sensitivity was found when CHOP was over-expressed in these cells.    
Though a CHOP responsive cis-element and a few downstream targets have 
been identified, the precise role of CHOP in gene regulation and physiology is not 
clear.  The sense CHOP cell line after NO treatment shows a massive increase in 
CHOP expression, when compared to basal CHOP expression in SH-Sy5y cells (see 
Fig. 13B).  This should be exploited in micro-array analysis to positively identify 
CHOP-regulated transcriptional targets specific for apoptosis. A differential micro 




responding to over-expressed CHOP alone, could also help identify (any) NO-specific 
regulation of the transcriptional activities of CHOP, apart from the initial NO mediated 
up-regulation of the CHOP protein itself.    
 
3.3 Bcl-2 is a downstream mediator of NO induced apoptosis 
3.3.1 Bcl-2 over-expression in SH-Sy5y cells 
In an attempt to characterize the ‘global’ transcriptional response to NO, a 
screening project was undertaken as mentioned previously.  Through the use of a 
transcription factor array (Panomics), various transcription factors were identified and 
shown to bind with increasing/ decreasing affinity to their respective consensus 
elements (S. Dhakshinamoorthy, unpublished).  In parallel, the expression profiles of a 
few candidate NO-induced apoptosis-regulating genes were examined, some of which 
might be up- or down-regulated via the identified NO-activated cis-elements.  Bcl-2 
mRNA and protein were found to be strongly up-regulated starting from 2 hours of 
NO treatment of SH-Sy5y cells (S. Dhakshinamoorthy, unpublished).   
Analysis of the bcl-2 promoter showed the importance of an upstream CRE 
element in mediating the transcriptional up-regulation of the gene after NO treatment.  
Deletion analysis of the bcl-2 promoter showed the presence of at least three 
regulatory elements -- two SP-1 sites and a CRE (S. Dhakshinamoorthy et al., 
unpublished).  The CRE element has been implicated in neuronal cell responses to 
hypoxia via Bcl-2 protein induction (Freeland et al., 2001).  A similar correlation 
between NO-mediated up regulation of Bcl-2 mRNA and subsequent cyto- protection 
was observed here.  Luciferase assays using the bcl-2 heterologous promoter and the 
isolated CRE showed NO inducibility starting from two hours of treatment with NO 




in the bcl-2 promoter totally abolished this response (S. Dhakshinamoorthy, 
unpublished).     
I developed Bcl-2 over-expressing stable neuroblastoma cell lines to determine 
if Bcl-2 plays any role in protecting cells from NO-induced apoptosis.  This mimics 
the NO-dependent upregulation of Bcl-2 mRNA and protein and would implicate Bcl-
2 in protecting SH-Sy5y cells from NO-mediated apoptosis (especially given the 
abundant evidence supporting Bcl-2 as an anti-apoptotic protein in cells). 
Stable over-expression of Myc-tagged Bcl-2 was confirmed in three selected 
independent clones of SH-Sy5y cells by Western blotting (Fig. 15A).  Cell death 
assays were then set up to examine the effect of the over-expression of the protein.  
Sytox-Hoechst staining of the cells showed up to 30% protection from NO-mediated 
cell death at 24 hours after NO treatment (Fig. 15C).  Similar results were obtained 
with LDH release assays performed in parallel for the Bcl-2 clones, vector control and 
wild-type SH-Sy5y cells (data not shown).   
Caspase-3 cleavage was examined next. The Bcl-2 clones showed a near 
complete absence of caspase-3-like cleavage activity even 16 hours after treatment 
with NO (Fig. 15B).  This was also reflected in the absence of the 17-kDa cleaved 
caspase-3 products in Western blots performed with protein extracts of Bcl-2-
overexpressing clones (prepared after 16 hours of NO treatment) when compared to 
the vector control cells (Fig. 16A).  Protection from apoptosis was also indicated by 
the fact that the 89-kDa cleaved PARP band was virtually absent in the Bcl-2 stable 
cells, even after 16 hours of NO treatment (Fig. 16B).  Next, cytochrome c release was 
examined by immunoflourescense. Bcl-2 over-expression appeared to delay 
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Figure 15.   Stable Bcl-2 over-expression in SH-Sy5y cells.  (A) Western blot 
analysis of SH-Sy5y, vector control and three selected clones over-expressing 
Myc-tagged Bcl-2.  The top panel, probed with Bcl-2 antibody, shows tagged 
bcl-2 migrating 4 kDa above the native protein.  Western blotting with the Myc
antibody reveals only the tagged proteins in the stable clones (the panel below).  
(B) SH-Sy5y, vector and stable Bcl-2 cells were treated with 2 mM SNP for 12, 
16 and 24 hours, before assay for caspase-3 cleavage.  (C) Sytox-Hoechst 
staining of vector and Bcl-2 clone A cells after 16 hours of treatment with 2 mM
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Figure 16.  Bcl-2 over-expression protects SH-Sy5y cells from NO-mediated cell 
death.  (A) Western blot analysis of SH-Sy5y, vector control (V) and Bcl-2 over-
expressing clones, A, B and C, showing caspase-3 cleavage in cells treated with 
1.5 mM Deta-NO for 16 hours.  The un-cleaved 30 kDa and the cleaved 17-kDa 
bands are seen.  (B) Western blot analysis, as above, but showing PARP cleavage.  
The un-cleaved 116 kDa and the cleaved 89 kDa bands are seen. (C), cytochrome
c release.  Vector control and Bcl-2 over-expressing cells treated with 2 mM SNP 
for 16 hours and stained with FITC-cyt c antibody and a red-colored mito-tracker.  
The third panel shows the merged pictures – co-localization in mitochondria is 
seen as yellow coloured stains; the cytochrome c release into the cytosol looks 
more apparent in the ‘vector’ cells than in the Bcl-2 clones, where the red 
mitotracker appears to co-localize mostly with the green cyt c, in the 
mitochondria, even after NO treatment.





with endogenous levels of Bcl-2, further confirming its overwhelming cytoprotective 
role of Bcl-2 (Fig. 16C).   
 
3.3.2 Discussion 
Overexpression of the Bcl-2 protein protects a wide variety of cell types from 
many death-inducing stimuli including growth factor withdrawal, treatment with 
calcium ionophores, glucose withdrawal, membrane peroxidation, glucocorticoid 
treatment, chemotherapeutic agents, and virus infection, implying that Bcl-2 functions 
at the point of convergence of many different signals.  Bcl-2 is known to bind and 
inhibit pro-apoptotic family members; regulate ion flux across the mitochondria and 
stabilize the membrane potential and thus regulate cytochrome c release.  It is also 
known to inhibit ROS production.  Bcl-2 has also been implicated in regulation of 
VDAC (voltage-dependent anion channel) and thus the ATP/ ADP ratio of the cell; all 
of which make it among the most prolific of all the cyto-protective proteins of the cell 
(Cory et al., 2003). 
Our study showed for the first time the protective role played by Bcl-2 in NO-
induced apoptosis of neuroblastoma cells. The evidence for such protection came from 
transcriptional up regulation of Bcl-2 mRNA and protein (S. Dhakshinamoorthy, 
unpublished), and from my further experiments confirming the strong protection 
afforded by over-expressed Bcl-2 in the presence of NO. Bcl-2 up-regulation was 
observed as early as two hours after NO treatment, well before the onset of cell death, 
which further indicates its importance in counteracting NO-induced apoptosis. These 
results altogether emphasize the importance of death signal-mediated regulation of 





CHAPTER 4 – CONCLUSIONS AND FUTURE DIRECTIONS  
The study of transcriptional regulation of apoptosis and particularly NO-
mediated apoptosis are relatively new fields.  There is little information on specific 
details of the cascades of kinases or other modulators affecting specific transcription 
factors and appropriate downstream targets that modulate apoptosis.  Variation in NO 
treatment regimens, the type of donors used, the duration of treatment, the redox status 
of the cells, hinders the development of uniform models of transcriptional cascades in 
mammalian cells downstream of NO.  Thus, the available literature often shows 
contradictory roles for even the same transcription factor, as seen in the case of AP-1.  
The large family of AP-1 dimers is known to counteract cell death induced by DNA 
damage as well as protect macrophages from excess NO (via c-jun).  In 
undifferentiated neuroblastoma cells, AP-1 affords protection from NO-induced 
apoptosis, in part through the expression of  neuroprotective NCAM-140 (Feng et al., 
2002); but in contrast, toxic concentrations of NO lead to c-Jun phosphorylation on 
Ser-63 by JNK that triggers apoptosis in the same cells, via unknown c-Jun targets (Li 
et al., 2004b). 
In this study, I have shown evidence for NO-mediated phosphorylation of AFX 
without nuclear exclusion (see Figs. 7B and 8A). These effects appear to be concurrent 
with modification of the DNA-binding and transactivation potential of FOXO factors 
in reporter assays (see Figs. 5A, 6B).  Interestingly, over-expression of AFX alone is 
toxic to cells, suggesting AFX is pro-apoptotic in neuroblastomas, but it remains to be 
determined whether this killing depends on S197 phosphorylation. It will be important 
to identify the actual downstream targets of phosphor-AFX that might regulate the cell 
sensitivity to apoptosis.  Furthermore, the role of other FOXO factors such as FKHR 




of mRNAs that are either up- or down-regulated by NO treatment, such as GADD45-
α, catalase, Bcl-6, p130, and cyclin D1 (see Fig. 11). It is interesting that the regulation 
of these genes by NO occurs early after NO treatment and well before the onset of cell 
death, allowing the possibility these genes can govern cell viability under NO stress.    
Cell death assays with SH-Sy5y stable cell lines that express S197A site-
directed mutants of AFX will also help us better understand the significance of this 
particular serine phosphorylation. If this is not important, other serines in AFX that are 
known to be phosphorylated in other systems should be investigated. Identification of 
the upstream kinases that phosphorylate AFX downstream of NO will also be useful. 
We have considered ER stress as being a significant contender for mediation of 
NO-mediated apoptosis by examining the status of CHOP in neuroblastoma cells.  Up-
regulation of endogenous CHOP by NO coincides with the onset of apoptosis, 
implying a role for CHOP in the demise of the cell by apoptosis. The small 
sensitization and protection (from cell death) seen with CHOP over-expression and 
knockdown, respectively, although disappointing, may implicate the unfolded protein 
response-ER stress pathway, but the precise role of CHOP as a transcription factor 
contributing to these effects is still not clear.  The CHOP sense stable cell lines will be 
useful to identify CHOP-regulated genes (by micro-array) that contribute to NO-
mediated apoptosis in mammalian cells. 
The cyto-protection shown by the transcriptional up-regulation of Bcl-2 (see 
Fig. 15C) is further evidence for the existence of transcriptional control in cell 
survival.  A better under standing of the transcriptional profiles in response to NO, the 
identification of all the relevant transcription factors and their possible NO-mediated 




sensitize cells to apoptosis, is necessary before suitable applications can be considered 
to counter various NO-mediated pathologies in neurons and other mammalian cells.  
The role of endogenously produced NO, the molecular identity of the active 
nitrogen species, its primary target molecules, the chemical modification(s) induced, 
and the mechanism of action have not yet been defined in vivo.  To this end, 
replication of experiments in this study and other studies done on transformed cell 
lines with chemical NO donors will need to be done in primary cell lines or in in-vivo 
conditions in order to have better understanding of the relevance of NO in 
physiological situations.  The latter will be particularly significant when the attempt is 
to understand the ‘global’ response to NO in mammalian cells. 
The relevance of low levels/ endogenous levels of NO to cell signaling is 
relatively well studied. Only recently has the ‘signaling’ possibilities of cytotoxic 
levels of NO been studied. The published literature as well as studies in our own 
laboratory emphasizes the complexity of this task. NO, with its wide ranging 
pleiotropic effects on kinases, phosphatases and transcription factors, along with other 
crucial modulators, appears to be capable of drastically modulating gene transcription 
and thereby influencing the physiological and patho-physiological status of the cell.  
Cytotoxic levels of NO have been found to induce time-dependent cascades of 
transcriptional events, where the early events involve the induction of metabolic and 
cyto-protective genes and the later events involve the activation of pro-death genes 
(Hemish et al., 2003). The relevance of transcription itself, however, with reference to 
the preparation of the cells for, and the induction of apoptosis, is still controversial.  
Further analysis of transcriptional events dictated by cytotoxic levels of NO is a valid 
approach to achieve a better understanding of the molecular events in 
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